TSS:Rfhg 134228.1

Basic information about the TSS

---

TSS ID: rfhg_134228.1 Species: human Chr: chr11		Start: 10802100 End: 10802119 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000532120.1:-227 GeneID: 1982 HGNC/MGI_ID: HGNC:3297 UniProt_ID: Nearer transcript ids and distances: NR_004403.1:492

Gene_name: SNORD97 Gene_symbol: EIF4G2 Gene_synonyms: DAP5 NAT1 p97 Gene_source: HGNC:3297

TATA-Box annotation

---

Distance to TSS:	-501
Nearest PromoterID:	NR_004403
Entrez ID:	692223
Nearest Unigene:	Hs.723086
Nearest Refseq:	NR_004403
Nearest Ensembl:	ENSG00000238622
Gene Name:	SNORD97
Gene Alias:	U97
Gene Type:	snoRNA
CpG%:	0.000000
GC%:	0.550000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EIF4G2 p2@EIF4G2 p3@EIF4G2 p4@EIF4G2 p6@EIF4G2 p7@EIF4G2 p9@EIF4G2 p10@EIF4G2
Sample		p1@EIF4G2	p2@EIF4G2	p3@EIF4G2	p4@EIF4G2	p6@EIF4G2	p7@EIF4G2	p9@EIF4G2	p10@EIF4G2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	1186.16	1.56	0.19	3.31	3.70	2.14	0.97	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	1122.26	1.82	1.01	4.05	3.44	1.42	0.61	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	1207.77	2.51	0.96	5.40	3.09	1.35	1.35	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1190.70	2.91	0.62	2.08	2.49	0.42	0.62	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1151.60	3.15	2.92	2.02	2.47	1.80	0.90	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1161.31	3.49	0.78	1.94	3.10	1.55	0.39	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1315.58	5.88	1.09	4.14	2.83	2.18	0.87	2.40
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1268.50	2.42	0.73	3.39	1.70	1.45	0.48	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1166.25	2.14	2.35	2.35	1.71	0.43	1.28	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1331.98	5.80	2.32	5.80	2.90	1.16	1.74	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1259.59	3.23	1.62	0.40	3.23	0.40	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1428.22	2.44	2.44	1.22	1.63	2.03	0.41	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	772.11	1.93	1.29	3.39	1.29	0.48	0.81	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	646.51	2.41	0.45	3.16	1.95	0.90	1.20	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	747.14	0.66	1.76	1.98	2.20	0.88	0.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	593.52	3.52	2.01	2.77	2.51	1.51	0.50	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	588.39	2.18	0.44	2.62	1.97	0.22	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	540.35	3.80	0.84	4.22	1.27	1.69	1.27	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	556.61	3.73	0.53	2.13	1.60	1.07	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	641.33	2.56	0.45	2.26	2.11	0.75	0.45	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	579.11	2.81	1.34	2.67	1.47	0.94	0.67	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	627.66	1.90	0.52	2.59	1.04	1.04	0.52	1.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	555.55	2.20	0.90	2.33	2.07	1.16	0.39	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	554.50	1.70	0.97	3.15	2.18	0.24	0.24	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	671.03	1.81	1.81	1.81	2.06	0.77	0.26	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	566.24	2.53	0.00	2.22	1.90	1.27	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	569.79	4.95	1.10	2.75	0.55	1.10	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	718.81	4.24	0.47	2.59	2.12	1.41	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	574.70	2.58	0.48	2.10	1.29	0.81	0.48	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	641.88	2.17	0.90	2.90	0.36	0.18	0.36	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	564.81	3.14	0.21	3.35	1.88	1.26	0.63	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	647.69	1.76	0.20	2.15	1.37	0.59	0.78	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	577.16	4.01	1.27	4.01	1.69	0.63	1.48	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	735.80	4.45	0.33	3.79	1.98	1.65	0.16	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	692.05	2.24	0.93	4.30	1.68	1.12	0.37	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	653.63	1.15	0.96	2.68	2.49	1.15	0.19	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	719.42	2.04	0.61	4.29	2.66	1.23	0.82	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	577.06	1.21	0.40	0.20	2.42	0.81	1.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	650.14	2.97	0.00	2.16	2.43	1.08	1.35	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	670.97	2.64	0.72	1.44	1.68	0.72	0.00	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	598.97	1.41	0.47	3.76	0.47	0.47	0.47	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	710.74	3.22	0.15	2.20	1.61	1.32	0.44	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	795.07	2.32	0.84	2.32	1.48	1.27	0.63	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	814.52	3.50	1.05	2.97	2.97	1.22	0.52	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	810.92	3.81	0.60	3.01	2.01	1.41	1.61	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	790.30	3.02	1.63	4.42	3.72	2.09	0.93	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	760.74	1.68	0.72	1.44	1.68	0.96	0.24	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	794.01	1.19	0.00	2.38	2.09	0.30	0.89	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	850.26	0.96	0.72	2.15	2.39	0.96	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	881.58	2.63	0.81	3.64	0.61	0.20	0.40	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	984.39	3.48	1.43	3.48	3.89	2.66	0.82	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	1159.46	3.11	2.22	5.56	3.11	2.89	2.00	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	2826.42	41.98	0.00	55.97	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	649.75	2.84	3.19	2.13	1.42	1.77	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	630.29	2.65	0.99	4.64	1.33	0.66	0.33	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3294.51	4.19	2.52	27.68	15.10	7.55	7.55	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1456.26	4.59	0.46	5.51	4.59	1.84	1.38	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	980.10	1.30	3.57	6.16	3.89	1.94	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	826.69	2.89	5.46	3.53	3.21	1.28	0.32	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	2025.86	5.03	0.31	5.66	5.97	2.51	2.51	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	554.88	2.82	6.35	3.53	3.53	2.12	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	507.51	3.93	1.68	4.49	2.80	2.24	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5137.51	11.15	3.98	13.53	10.35	8.76	4.78	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1658.75	3.40	0.68	5.44	3.40	1.36	1.02	4.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	1237.95	2.60	8.77	4.55	3.57	2.27	1.30	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	786.63	2.13	3.19	5.68	1.42	3.90	1.06	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1713.38	0.00	0.00	32.33	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	2392.94	0.00	0.00	31.59	7.90	15.79	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	487.52	2.44	2.93	3.41	5.36	3.90	1.95	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	581.66	0.50	2.98	3.47	1.49	1.49	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	600.00	0.94	0.94	1.88	1.88	1.88	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1386.36	2.65	1.66	3.64	1.99	0.99	0.99	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	690.45	0.31	4.33	5.26	4.02	2.47	0.93	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	547.28	1.83	5.50	3.36	3.06	1.22	0.31	2.14
Adipocyte - breast, donor1	11376-118A8	1191.05	11.25	0.48	1.74	1.58	1.27	0.79	0.48
Adipocyte - breast, donor2	11327-117E4	664.65	6.74	0.32	7.38	6.90	5.61	2.73	2.73
Adipocyte - omental, donor1	11473-119C6	1382.96	9.41	0.51	1.27	1.91	2.54	1.02	0.64
Adipocyte - omental, donor2	11474-119C7	643.59	1.49	0.00	4.48	6.73	0.75	0.00	2.24
Adipocyte - omental, donor3	11475-119C8	700.32	5.69	0.33	3.01	3.68	1.34	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	594.61	1.91	0.00	4.47	5.10	3.19	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	185.82	6.60	0.00	0.00	1.10	0.00	0.00	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	742.92	12.65	0.00	2.71	0.90	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	434.27	4.00	0.35	1.91	0.87	0.87	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	1570.25	8.41	1.37	0.98	1.56	0.98	0.78	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	1033.63	3.09	0.77	2.32	1.03	1.03	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	911.03	5.58	1.12	2.23	0.84	1.39	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	1562.40	4.70	0.00	1.76	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	1711.70	10.13	0.80	1.21	1.05	0.48	0.24	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	1125.45	4.52	3.23	2.58	1.61	1.61	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	889.36	5.33	0.00	3.73	1.07	2.13	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	1223.05	3.90	3.34	5.01	0.00	2.23	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	580.58	4.16	0.83	0.83	0.42	0.42	1.66	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	767.31	2.01	0.25	1.26	0.50	1.00	0.75	1.76
Adipocyte differentiation, day12, donor3	13027-139E3	793.57	3.60	0.65	3.27	0.98	2.29	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	881.14	2.13	1.22	1.83	0.30	0.30	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	559.12	0.44	0.00	0.44	0.66	1.10	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	188.61	0.00	1.79	0.72	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	101.83	1.20	0.00	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	1109.48	0.18	0.72	0.54	0.36	0.72	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	394.94	0.00	0.00	3.35	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	548.34	2.67	0.00	1.03	0.41	1.23	0.00	0.41
Anulus Pulposus Cell, donor1	11248-116E6	710.58	2.52	0.46	2.17	0.57	0.69	0.46	0.34
Anulus Pulposus Cell, donor2	11463-119B5	609.82	1.71	0.73	0.49	0.73	0.49	1.22	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	539.60	4.94	0.90	3.59	3.15	1.35	2.25	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	601.72	2.17	1.30	3.47	3.04	3.47	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	398.09	2.14	0.00	6.42	2.14	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	586.49	2.09	0.60	5.08	4.48	2.69	1.20	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	579.21	2.53	0.00	5.06	3.79	3.79	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	460.07	4.62	0.66	1.98	1.32	1.98	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	485.38	2.27	0.65	2.92	1.95	0.32	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	572.82	0.97	0.49	2.43	2.91	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	408.59	1.19	0.59	3.56	1.19	2.38	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	554.79	1.51	0.00	7.16	2.26	1.88	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	550.79	1.45	0.73	2.90	0.73	0.73	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	362.34	1.25	0.00	8.78	7.52	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	813.47	1.65	0.00	0.99	0.99	0.49	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	575.95	0.00	1.36	5.46	2.73	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	790.90	0.45	0.00	2.11	1.66	0.45	0.30	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	618.30	3.21	1.07	2.14	1.61	0.54	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	655.80	1.70	1.32	4.16	1.32	1.51	1.89	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	688.53	2.14	0.80	6.68	2.14	2.14	1.60	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	454.56	1.95	1.95	4.88	3.90	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	618.66	1.16	1.00	2.16	1.33	0.33	0.33	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	463.48	8.41	0.00	7.20	6.00	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	598.29	0.00	0.00	3.54	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	653.70	1.72	0.34	1.54	1.72	1.72	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	360.77	4.19	0.00	4.19	12.58	4.19	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	552.41	2.43	0.97	5.83	3.88	2.43	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	644.31	1.52	0.00	1.90	0.76	1.52	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	425.19	4.85	1.21	3.63	9.69	4.85	2.42	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	542.67	2.28	0.57	5.13	3.99	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	594.29	0.86	0.43	2.78	1.92	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	570.89	1.29	0.52	3.87	3.10	1.03	0.52	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	554.13	0.94	0.47	5.16	1.88	1.41	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	597.44	1.93	0.00	3.86	2.89	2.25	0.64	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	441.63	1.43	0.71	1.43	0.71	0.71	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	455.09	0.58	0.00	3.51	1.75	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	652.73	1.20	0.90	3.01	1.81	2.11	0.90	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	548.85	2.38	1.19	4.75	4.75	1.19	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	492.79	4.58	0.00	4.07	3.56	0.00	2.03	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	633.66	2.80	1.53	4.84	4.84	2.04	1.02	2.55
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	431.42	0.00	0.00	2.54	0.64	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	507.05	3.02	0.00	5.18	3.88	0.43	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	630.19	1.27	1.06	2.12	0.64	0.42	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	496.16	0.87	2.32	2.61	0.87	1.45	0.58	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	566.84	1.89	0.94	7.56	1.89	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	607.75	0.85	0.00	1.70	1.36	0.17	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	463.27	0.00	2.32	4.63	2.32	2.32	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	553.49	0.00	0.00	2.11	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	671.11	0.21	0.21	2.36	1.93	0.86	1.29	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	588.43	1.20	0.60	1.20	3.61	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	536.53	3.64	0.73	5.10	2.19	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	602.29	1.15	0.92	2.53	1.84	0.92	0.92	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	494.76	0.00	0.00	17.85	2.55	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	864.64	1.02	0.00	1.53	2.54	1.53	1.53	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	741.94	1.24	1.03	4.34	2.27	0.41	0.41	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	588.44	0.61	0.31	3.06	1.22	1.22	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	614.72	1.91	0.48	5.26	1.91	1.91	1.43	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	695.60	1.55	0.44	2.22	2.66	2.00	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	363.14	1.53	0.00	3.05	6.10	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	485.76	2.77	0.00	2.77	1.66	1.66	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	672.84	1.32	0.53	2.12	2.12	1.85	1.32	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	499.38	1.82	0.36	2.91	1.82	0.00	0.00	1.09
Astrocyte - cerebellum, donor1	11500-119F6	874.45	0.74	0.49	0.25	0.00	0.00	0.12	0.37
Astrocyte - cerebellum, donor2	11580-120F5	422.42	0.51	0.68	0.86	0.34	0.00	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	255.68	0.42	0.84	0.42	0.00	0.00	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	1253.86	3.14	0.00	2.09	1.74	1.39	0.35	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	1165.26	3.07	0.65	7.12	2.59	2.43	1.13	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	1095.13	2.68	0.45	4.92	1.49	1.19	0.89	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1103.96	3.44	0.34	4.82	2.18	2.87	1.26	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1493.48	3.76	1.50	3.38	2.63	1.75	0.88	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1443.17	1.59	1.14	3.07	2.16	1.71	0.80	0.23
Basophils, donor1	12241-129G9	1173.76	2.35	0.00	0.52	0.26	1.05	1.05	0.00
Basophils, donor2	12242-129H1	2638.49	4.33	0.00	2.53	1.44	0.72	0.36	0.00
Basophils, donor3	12243-129H2	1448.66	1.91	0.73	1.91	0.73	0.44	0.29	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	353.59	1.08	0.00	0.00	1.51	0.43	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	176.93	0.00	0.91	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	473.46	0.00	0.00	0.00	14.35	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	684.77	3.14	3.77	1.26	1.26	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	660.03	2.50	0.21	0.42	0.00	0.42	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	513.32	2.30	0.69	0.69	2.07	1.38	0.92	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	507.27	1.44	1.08	1.62	2.34	1.08	1.08	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	847.42	1.34	0.62	1.34	0.82	0.82	0.10	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	1227.87	1.40	1.63	2.56	1.86	1.16	0.47	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	841.65	0.32	0.00	0.96	0.32	0.00	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	579.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1572.88	2.25	1.13	0.56	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	1076.11	4.83	4.08	3.71	4.64	2.60	1.67	0.74
CD14+ Monocytes, donor3	11381-118B4	1007.89	0.88	2.85	3.73	1.54	1.32	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	899.80	10.76	0.57	1.13	1.13	0.00	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1204.70	12.13	1.14	0.38	0.38	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1510.56	6.90	0.66	1.64	0.66	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	1427.42	10.84	0.72	6.94	5.35	3.76	1.59	2.46
CD14+ monocytes - mock treated, donor2	11873-125C1	1627.60	8.75	0.60	5.73	2.41	3.02	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	2100.53	7.82	0.71	6.63	1.90	2.37	0.95	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1684.53	4.85	2.68	5.02	3.52	3.85	1.17	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2070.92	4.97	1.10	6.90	2.48	3.31	0.55	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2069.71	6.45	0.74	4.71	4.21	3.97	0.99	1.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1077.88	1.57	0.39	6.07	2.35	3.13	0.59	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1145.39	1.60	1.07	6.05	2.14	1.42	0.71	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1707.53	1.09	0.22	4.57	4.13	2.61	2.18	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1236.19	11.47	2.81	5.62	2.11	3.75	0.70	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1442.04	7.39	2.64	8.98	2.11	4.22	1.06	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1066.09	1.11	1.11	3.33	2.22	2.22	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1295.60	13.54	0.15	6.84	5.95	4.91	2.83	2.23
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1598.98	10.78	0.60	5.19	2.59	3.99	1.60	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2313.93	8.12	1.04	2.91	4.79	4.58	0.62	2.29
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1637.87	24.02	1.14	7.55	5.49	4.58	2.29	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2493.90	14.48	0.00	3.85	2.04	4.07	0.90	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1701.76	24.01	0.44	6.98	2.62	3.93	1.75	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1272.59	3.50	2.15	4.57	2.15	2.15	0.81	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1221.75	5.06	1.57	5.06	2.62	2.97	0.52	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1617.63	2.95	0.84	5.47	1.26	3.79	0.84	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1488.61	5.14	0.92	7.53	6.06	6.98	2.76	1.84
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2649.04	3.17	1.06	6.69	1.06	5.64	0.35	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2574.44	7.90	1.75	3.51	3.51	2.19	2.19	2.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1058.10	2.09	1.74	5.41	4.01	2.96	1.22	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1237.68	0.37	3.35	3.35	2.23	3.35	1.49	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2020.34	3.88	0.43	4.53	2.16	4.10	1.72	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1328.38	3.69	4.50	5.32	2.46	6.14	0.82	2.46
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2418.59	1.62	0.46	3.71	1.85	1.62	0.46	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2448.44	3.71	0.46	4.18	3.71	4.64	1.16	2.09
CD14+CD16+ Monocytes, donor1	11789-124B7	838.29	0.87	0.44	1.96	1.74	3.27	1.96	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	754.66	3.46	0.00	1.39	1.39	1.85	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	729.78	0.65	0.22	0.87	2.17	1.08	0.00	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	937.76	2.34	0.47	1.71	0.78	1.25	0.16	1.40
CD14+CD16- Monocytes, donor2	11799-124C8	857.68	2.79	0.17	1.57	0.87	1.57	0.35	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	2222.11	4.46	1.34	1.56	2.01	2.68	0.89	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	626.45	2.04	0.00	1.53	1.02	0.77	0.77	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	641.57	2.42	0.00	3.29	2.20	1.32	0.44	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	920.93	1.47	0.00	1.05	0.84	0.42	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	884.05	0.00	0.00	0.00	2.03	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	865.10	2.71	0.00	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1027.31	2.07	0.00	1.04	0.00	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1034.09	2.67	0.53	2.13	1.07	0.53	0.53	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1294.07	2.14	0.00	1.07	3.22	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	939.90	1.40	0.00	0.00	0.70	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	955.34	3.14	0.00	0.78	0.78	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1077.04	2.64	0.00	1.32	0.00	1.32	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	1194.22	4.11	8.22	5.75	2.47	0.82	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	1000.36	3.63	9.43	4.35	0.00	2.18	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	1083.36	7.07	6.06	1.01	2.02	1.51	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1698.66	3.23	0.00	2.02	1.62	0.00	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1238.02	1.20	0.00	0.40	0.40	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	435.76	1.00	0.00	2.01	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	1128.67	0.56	0.00	0.00	0.56	0.56	1.12	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	751.13	1.13	2.25	1.13	1.50	1.13	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	947.71	1.13	0.00	1.35	0.23	0.23	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	2078.79	5.00	5.00	0.71	1.07	1.43	0.71	1.79
CD4+ T Cells, donor2	11306-117C1	1368.02	6.74	17.76	14.70	14.70	7.35	3.06	3.67
CD4+ T Cells, donor3	11382-118B5	1324.59	4.27	7.93	3.35	4.27	2.13	1.52	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	707.52	5.10	0.00	1.79	1.02	2.30	0.77	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1036.07	1.80	2.02	1.57	1.35	1.12	0.22	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1015.60	2.01	1.72	1.44	1.15	0.86	0.57	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	706.40	0.47	0.00	1.90	3.79	1.42	0.95	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	617.34	0.70	0.00	0.70	1.40	0.70	0.70	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	741.65	3.30	3.30	0.00	0.00	6.59	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	760.87	2.75	0.29	2.17	2.31	0.72	0.43	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	849.86	2.03	3.90	2.37	3.22	1.86	1.69	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	768.15	1.93	4.51	3.39	2.26	2.42	0.32	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	751.35	0.90	1.79	0.90	2.24	0.90	0.45	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	693.54	1.40	1.05	1.75	2.10	1.40	0.35	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1064.75	2.64	2.20	1.76	2.20	3.08	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	880.81	2.11	0.42	1.69	1.26	0.84	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	672.55	1.45	4.99	2.08	0.83	1.45	0.21	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	650.88	0.67	5.01	0.00	1.67	2.34	0.67	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	886.51	3.81	0.54	1.63	2.18	0.82	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	937.91	4.82	0.54	4.29	1.07	1.61	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	876.89	7.17	10.76	7.17	0.00	3.59	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	986.85	2.78	0.74	1.67	1.48	0.74	1.11	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	796.07	3.03	0.43	1.95	1.52	0.22	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	973.42	2.52	0.63	1.05	1.47	1.47	0.42	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	639.08	1.52	0.00	1.52	3.03	1.01	0.51	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	645.98	3.03	0.43	0.43	1.30	0.43	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1166.68	3.05	1.31	3.49	1.31	1.74	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1204.02	3.46	0.00	1.48	1.48	0.49	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	855.79	0.92	0.00	1.85	2.77	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	750.95	1.40	0.00	1.40	1.40	1.40	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1324.55	5.82	0.00	0.28	0.55	1.11	0.00	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1437.01	4.17	0.25	1.23	1.96	0.74	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1324.41	3.08	0.00	0.00	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1099.78	2.86	0.00	1.79	0.36	1.43	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1067.83	1.38	0.00	1.38	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	1821.63	4.58	5.24	1.64	1.96	1.96	0.65	0.98
CD8+ T Cells, donor2	11307-117C2	1158.58	6.01	10.89	10.51	9.39	6.01	1.50	2.63
CD8+ T Cells, donor3	11383-118B6	1417.98	4.29	8.33	3.79	4.80	2.52	1.26	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	983.63	1.15	2.29	3.67	3.44	0.46	0.23	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	906.81	0.72	2.16	4.07	3.35	3.12	0.72	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	927.20	2.19	1.64	4.10	3.01	2.19	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1076.56	1.50	1.20	4.80	1.80	0.90	0.30	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	826.74	1.68	1.44	1.68	3.12	1.44	0.24	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	955.25	0.68	1.36	2.73	1.59	1.36	1.82	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1074.47	0.87	1.30	3.04	2.82	0.43	0.43	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1152.31	2.37	1.84	3.16	1.84	1.32	1.58	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1059.31	0.47	2.81	3.75	2.35	2.11	0.47	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1084.34	0.60	1.51	6.04	5.43	3.02	1.21	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1023.74	1.16	1.45	3.49	3.78	0.87	1.16	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1150.73	0.53	0.27	1.60	2.93	1.07	0.80	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	1179.74	2.19	10.51	0.88	0.44	2.19	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1020.62	1.37	6.83	2.73	0.00	1.37	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2303.25	0.75	38.04	2.24	0.75	2.24	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	969.54	2.16	0.72	2.52	0.72	1.08	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	1068.60	3.45	3.45	0.86	2.30	1.15	2.01	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	912.38	1.89	1.18	1.65	1.41	0.24	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	992.86	2.22	0.63	3.49	3.49	1.90	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	1133.68	1.85	1.85	3.08	1.54	1.23	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	1095.11	1.28	1.92	2.56	2.56	1.92	0.00	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1012.00	1.91	1.53	1.53	2.29	0.76	1.15	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	963.19	1.18	3.55	1.18	3.15	1.18	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	923.58	0.00	1.51	5.29	1.51	3.03	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	1075.96	2.41	8.83	3.21	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1107.20	1.40	15.39	1.40	0.00	1.40	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	1042.82	0.00	7.01	1.00	1.00	4.01	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	1257.48	0.00	3.66	0.00	0.00	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	567.71	0.49	0.49	1.48	0.49	0.00	1.48	1.48
Cardiac Myocyte, donor3	11686-122I3	841.76	1.58	0.00	1.47	0.74	0.53	0.21	0.32
Chondrocyte - de diff, donor1	11261-116G1	1711.84	4.85	2.08	1.04	2.08	0.69	0.69	1.73
Chondrocyte - de diff, donor2	11338-117F6	757.66	2.13	0.71	2.84	0.36	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	496.30	3.64	1.37	2.39	2.50	1.48	1.71	1.25
Chondrocyte - re diff, donor2	11339-117F7	2925.70	34.02	0.00	5.37	2.69	2.69	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	544.73	3.24	0.81	2.43	2.43	0.00	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	1234.80	3.44	0.23	1.84	0.92	0.92	0.57	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	794.57	2.14	0.64	4.28	2.35	2.14	1.28	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	839.67	1.77	0.97	3.81	0.88	0.88	1.06	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	918.84	5.41	0.09	1.65	0.83	0.64	0.37	0.00
Corneal Epithelial Cells, donor1	11526-119I5	188.83	0.66	0.00	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	319.67	1.14	0.00	0.00	0.00	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	331.04	1.02	0.51	1.02	0.26	0.00	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1504.85	2.81	0.66	2.64	1.49	0.99	0.99	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1141.15	2.21	0.63	1.89	1.58	1.58	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	427.89	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	723.31	3.78	0.43	4.10	2.38	1.84	0.97	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1438.65	2.05	1.37	1.02	1.71	0.68	1.37	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1399.75	1.96	0.00	3.26	1.31	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1425.22	0.00	0.00	0.48	1.45	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	1229.75	2.50	0.17	1.17	0.33	0.83	0.83	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	570.35	0.00	0.00	1.17	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	1540.68	0.85	0.28	1.41	1.98	1.13	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	939.71	2.36	0.79	1.57	1.18	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	549.46	2.04	0.29	0.58	0.58	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	915.70	6.12	0.47	2.82	4.24	3.76	1.65	1.18
Endothelial Cells - Artery, donor3	11413-118E9	799.76	4.73	0.00	4.21	1.05	1.05	1.75	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	668.95	0.89	0.00	1.33	0.22	1.11	0.44	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	914.93	1.52	0.00	0.61	0.61	0.91	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	1324.66	3.66	0.00	1.41	1.69	1.69	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	765.42	4.75	0.00	0.59	0.59	0.30	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	746.11	0.52	1.04	1.04	0.00	0.52	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	326.39	3.69	0.28	1.28	1.13	0.14	0.43	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	1899.37	3.20	1.60	0.40	0.40	1.20	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	548.76	0.52	0.00	5.77	1.57	3.14	2.10	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1593.96	7.33	0.00	2.98	1.62	1.49	1.24	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	1546.90	3.26	5.21	2.39	0.87	1.09	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	1831.06	2.20	2.20	1.95	0.61	0.49	0.37	0.37
Endothelial Cells - Vein, donor1	11267-116G7	552.83	2.28	0.00	0.00	2.28	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	834.01	0.00	0.00	1.40	1.40	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	827.90	1.26	0.31	2.20	1.73	1.57	1.10	0.63
Eosinophils, donor1	12244-129H3	960.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1902.75	0.00	0.00	0.00	1.65	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	1098.58	3.57	0.00	0.00	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	275.36	0.24	0.24	0.00	0.49	0.98	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	193.46	0.00	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	715.83	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	1226.62	4.52	4.52	2.87	2.05	2.46	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	356.82	2.63	0.00	3.94	2.63	2.63	0.77	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	745.15	2.82	0.11	4.01	5.74	2.17	0.98	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	915.54	8.97	0.00	4.24	1.82	1.82	0.97	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	689.59	1.77	1.23	0.41	0.55	0.00	0.55	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	733.96	5.91	0.32	2.95	2.74	2.53	1.69	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	562.82	4.48	2.63	0.26	1.32	1.05	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	902.59	11.63	0.66	4.65	4.98	0.66	0.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	751.21	4.08	0.00	5.44	0.91	1.81	1.81	2.27
Fibroblast - Cardiac, donor2	11345-117G4	1123.28	3.03	0.00	0.76	0.76	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	414.00	2.52	0.32	1.26	1.26	0.47	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	1330.64	4.24	0.00	1.82	0.91	0.91	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	811.55	2.54	0.00	3.05	1.78	1.78	1.02	0.51
Fibroblast - Cardiac, donor6	11460-119B2	954.28	1.97	0.15	1.52	1.36	1.06	0.61	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	985.63	1.21	0.67	0.40	0.13	0.54	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	940.08	2.16	0.00	0.43	0.43	2.16	1.73	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	733.86	2.93	2.93	7.32	1.46	2.93	7.32	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	560.45	0.46	0.00	1.15	0.23	0.23	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	930.45	2.54	0.85	0.85	1.19	2.04	0.68	0.51
Fibroblast - Dermal, donor1	11269-116G9	500.79	2.58	0.47	1.17	0.47	0.23	0.94	1.64
Fibroblast - Dermal, donor2	11346-117G5	848.08	1.89	0.00	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	518.72	3.51	1.69	2.78	2.06	0.97	1.21	0.97
Fibroblast - Dermal, donor4	11450-119A1	1118.70	3.39	0.11	3.39	2.37	1.92	0.79	0.00
Fibroblast - Dermal, donor5	11454-119A5	1188.55	2.27	0.00	3.49	1.92	1.05	1.22	0.35
Fibroblast - Dermal, donor6	11458-119A9	1475.13	2.92	0.32	2.44	2.92	2.11	0.65	0.32
Fibroblast - Gingival, donor1	11237-116D4	1170.46	1.67	0.00	1.46	0.83	0.42	0.62	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	1517.24	14.93	1.57	3.67	1.05	3.14	0.26	1.05
Fibroblast - Gingival, donor2	11318-117D4	932.24	2.64	0.40	6.98	3.29	1.58	1.71	0.92
Fibroblast - Gingival, donor3	11394-118C8	1064.81	5.51	0.00	1.45	0.77	1.45	0.48	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	1303.81	23.89	1.04	2.08	0.00	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	820.76	9.69	2.64	5.29	1.94	1.94	0.88	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1457.16	3.90	0.94	2.65	1.87	1.87	0.62	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	1380.27	11.22	0.68	4.19	2.57	2.30	0.68	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	3800.16	3.53	0.35	0.35	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	1979.86	7.31	1.90	3.80	1.90	1.75	0.58	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1943.58	9.54	3.00	2.73	1.91	1.64	0.95	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	3036.20	11.08	2.19	6.36	2.08	3.18	1.65	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	1931.52	18.20	2.64	2.49	1.32	1.47	0.15	0.44
Fibroblast - Lung, donor1	11270-116H1	358.87	1.36	0.00	2.72	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	1123.59	1.49	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	602.72	1.69	0.42	3.80	1.69	1.27	1.27	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	755.55	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	450.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	110.27	0.28	0.00	0.00	0.00	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	1078.66	4.06	0.00	0.81	0.41	0.81	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	327.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	625.41	0.00	0.00	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	1344.63	2.13	0.39	1.94	1.36	0.58	0.97	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	1563.08	4.40	0.00	6.83	3.34	2.88	2.28	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	2507.87	2.45	0.00	1.84	0.00	0.92	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	1708.53	4.96	3.05	2.67	0.38	1.14	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	788.10	4.86	0.54	5.67	4.59	2.70	1.35	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	1015.47	8.93	2.09	1.62	0.93	1.16	0.58	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	887.69	1.88	0.00	1.99	1.77	1.33	1.55	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	834.10	1.02	0.00	0.81	0.00	0.81	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	434.33	1.34	0.00	0.67	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	521.88	0.00	0.00	0.79	1.58	0.40	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1088.29	2.18	8.33	1.39	3.37	0.99	0.40	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	1142.97	2.84	0.18	2.66	2.31	1.42	1.42	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	1422.76	2.37	0.20	2.37	1.77	1.97	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	676.62	0.60	1.20	0.30	1.20	0.60	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1898.33	5.51	0.54	1.19	1.40	1.94	0.54	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	726.58	2.02	6.07	1.52	1.77	1.52	0.25	0.76
Fibroblast - skin normal, donor1	11553-120C5	1179.23	3.45	0.00	0.98	1.97	1.64	0.66	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1212.67	0.80	3.61	1.40	0.80	1.60	1.00	0.80
Fibroblast - skin normal, donor2	11561-120D4	1637.13	6.53	0.20	2.41	1.71	1.61	0.80	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	906.11	1.81	6.35	1.51	1.21	1.81	0.60	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	1601.99	5.30	0.33	1.74	1.24	1.41	0.58	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	1676.85	8.38	0.17	2.22	2.22	2.39	0.34	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	799.08	2.96	1.31	0.66	0.99	0.99	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1668.77	5.75	0.00	1.60	1.38	1.49	0.75	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	1409.67	1.86	0.17	1.69	1.01	1.18	0.51	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1170.66	2.98	0.00	5.80	4.86	2.35	0.78	3.14
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	6514.98	0.00	0.00	88.64	22.16	22.16	66.48	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1253.26	5.23	3.49	4.36	0.87	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1221.30	6.41	0.00	1.56	1.39	0.87	0.87	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1245.25	8.59	0.52	2.08	0.52	1.04	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	1858.60	6.13	0.00	1.02	0.51	1.02	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1756.18	14.55	2.30	6.12	2.30	1.53	2.30	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1612.41	13.40	0.64	7.66	6.38	1.28	2.55	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3042.34	14.83	3.42	5.13	3.42	2.57	1.14	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	2789.28	45.50	7.17	4.41	3.58	2.76	0.83	3.03
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	2058.36	25.34	3.65	4.11	1.60	2.05	2.05	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	2660.29	16.64	4.76	1.78	3.17	2.18	2.18	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	2787.68	32.51	6.34	4.49	1.59	2.38	1.59	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2404.36	15.66	3.91	2.28	3.59	1.30	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	2546.77	9.73	2.65	1.77	3.10	3.98	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	911.53	4.52	1.55	3.82	1.98	2.83	0.42	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	859.90	5.91	0.86	3.69	1.48	1.48	2.22	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	896.40	5.10	1.61	2.42	3.22	2.69	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	1007.75	7.43	0.25	2.48	1.73	1.24	1.49	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	881.64	5.26	0.97	4.43	1.66	1.52	1.38	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	843.91	5.90	1.02	5.29	2.64	2.03	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	933.02	10.04	0.46	1.60	2.74	2.05	0.91	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	833.97	6.10	1.25	2.24	2.99	1.87	1.99	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	939.66	4.37	0.87	1.97	1.09	0.87	1.09	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	931.35	10.93	0.59	3.55	3.25	1.77	1.18	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	935.15	7.31	1.11	3.97	2.54	2.54	1.59	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	960.93	7.82	0.45	1.79	0.89	1.34	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	914.21	7.66	0.40	5.04	3.23	2.82	1.21	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	1056.53	5.77	1.19	4.58	3.56	1.19	2.54	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	1760.67	18.98	0.18	2.04	0.53	1.95	0.89	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2225.55	31.01	0.31	2.91	1.04	1.87	0.10	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2524.93	19.98	0.00	2.90	0.85	2.90	0.17	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	940.22	6.97	1.77	3.54	1.00	1.44	1.33	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	1357.01	12.73	0.50	1.00	1.58	1.41	0.42	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	1573.01	9.80	0.20	1.43	0.61	0.82	1.02	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	917.85	13.20	0.62	2.27	2.68	1.86	0.41	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	897.79	6.00	2.65	2.08	2.19	1.73	1.61	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	864.34	6.67	1.00	2.50	2.67	1.83	1.00	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	882.82	9.92	1.10	1.32	1.76	1.76	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	836.84	5.29	1.11	3.20	2.21	1.35	1.84	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	942.89	7.46	1.13	1.95	1.30	0.65	0.97	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	910.19	12.51	1.60	1.28	2.89	1.60	0.96	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	744.30	5.69	0.66	1.71	0.95	1.33	1.33	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	802.90	4.59	0.79	2.69	0.95	0.16	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	1041.80	15.81	1.22	2.43	1.52	3.04	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	812.89	7.53	0.94	2.09	1.78	0.84	1.99	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	716.41	3.07	1.76	1.32	1.76	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	927.21	9.26	0.28	1.68	1.68	1.40	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	1041.14	7.41	0.83	1.94	1.39	2.50	0.93	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	862.64	4.28	1.34	1.87	1.60	1.60	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	1122.90	6.73	1.38	2.75	2.60	2.60	0.46	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	867.51	3.89	0.91	3.24	2.20	1.55	1.94	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	764.15	5.15	0.54	2.71	0.27	1.63	1.36	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	976.51	4.98	0.92	2.21	0.92	1.66	0.37	1.47
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	879.44	4.82	0.66	3.51	1.54	2.41	1.32	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	2174.90	6.94	0.00	0.99	0.00	2.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	1029.84	8.18	0.40	1.98	2.11	2.51	0.40	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	928.28	4.64	0.81	3.03	1.82	2.02	1.21	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	3325.94	14.74	0.00	3.05	1.27	1.52	0.25	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1861.41	10.75	1.19	1.59	2.19	1.59	1.19	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	871.61	4.93	2.00	4.62	1.54	2.31	1.54	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1461.33	4.91	2.25	3.07	2.45	1.43	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1323.38	1.56	0.94	1.25	0.94	2.50	0.63	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1188.15	1.98	0.28	4.80	1.70	1.41	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	887.82	3.69	0.46	4.61	3.69	1.38	2.77	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1153.26	2.47	7.42	14.85	4.95	7.42	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1548.01	10.44	2.32	5.03	4.25	1.55	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1638.16	11.23	4.81	6.42	9.63	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	813.77	1.74	1.74	10.43	8.69	3.48	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1288.25	9.44	2.93	8.79	2.28	2.28	1.63	3.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1312.00	10.71	1.65	8.24	5.35	4.53	1.65	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1146.30	16.66	10.00	23.33	3.33	10.00	3.33	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1365.24	5.31	1.68	4.75	3.36	2.80	1.12	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1366.86	11.44	2.29	6.21	3.27	3.27	0.65	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	904.27	5.87	6.71	10.07	2.52	0.84	2.52	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1405.24	11.45	1.27	5.41	1.59	4.45	2.23	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1202.06	6.79	1.36	4.42	2.72	3.40	1.36	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	613.91	0.00	0.00	8.35	4.18	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1267.96	11.45	2.86	8.59	2.29	2.29	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	885.29	5.33	2.07	5.03	2.37	1.78	1.78	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	938.56	13.55	3.39	10.16	6.78	0.00	6.78	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1533.81	12.84	2.07	11.18	5.80	4.14	4.97	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1588.12	12.89	0.92	5.06	2.53	2.30	2.07	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	800.81	0.00	0.00	21.07	15.81	0.00	5.27	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1147.85	7.69	1.54	2.69	5.00	5.38	1.54	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1161.76	11.73	2.61	5.22	1.63	1.30	0.98	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	941.73	3.34	1.34	4.01	1.34	2.68	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1016.72	11.94	1.54	4.24	3.08	1.54	1.93	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1815.09	14.04	1.37	6.85	5.48	3.77	3.77	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	1113.19	9.94	4.97	7.45	4.97	2.48	4.97	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1183.87	12.27	6.13	3.77	2.36	1.42	0.94	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1059.73	6.64	3.62	4.83	3.62	5.43	3.62	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1065.17	3.56	4.07	5.60	0.00	1.02	0.00	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1291.04	14.36	3.19	6.78	4.79	2.39	3.19	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1070.58	8.88	5.92	5.43	1.97	0.49	0.99	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	751.94	1.18	9.44	1.18	4.72	3.54	4.72	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	895.59	12.25	2.33	5.25	2.33	3.50	1.17	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	853.19	7.90	4.83	3.95	3.51	1.76	3.07	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	1009.60	11.87	7.63	6.78	8.48	2.54	5.09	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	818.37	3.58	2.39	10.74	4.18	4.78	2.39	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	978.74	6.31	8.73	5.34	4.85	1.94	1.94	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	432.55	3.42	0.00	0.00	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	431.62	2.49	0.42	2.08	1.25	2.91	0.42	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	453.15	0.00	0.00	1.12	0.00	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	599.43	0.63	0.00	2.22	3.17	2.22	1.59	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	380.98	1.67	0.00	0.84	1.25	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	792.57	3.13	0.12	4.18	2.09	1.97	0.81	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	861.73	2.03	0.34	4.05	2.87	3.54	1.01	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	847.90	0.91	0.23	2.96	2.28	2.28	0.46	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	764.07	1.64	0.66	5.03	3.50	2.73	0.55	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	872.97	0.86	0.86	4.73	1.72	2.58	1.72	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	826.68	1.51	0.22	2.58	2.80	1.29	0.22	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	739.88	2.86	0.50	4.61	2.24	1.37	0.75	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	879.02	1.89	0.69	3.26	1.20	2.40	0.86	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	766.97	1.28	0.32	0.96	2.24	1.92	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	489.11	1.68	0.00	0.00	1.68	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	263.57	1.73	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	1070.74	5.29	5.29	5.29	7.93	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	549.54	1.41	0.00	1.41	0.00	0.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	263.72	0.73	1.45	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	802.69	2.45	0.87	4.55	1.92	2.45	0.70	1.75
Hepatocyte, donor1	11523-119I2	761.47	6.05	2.42	6.05	2.42	2.42	2.42	2.42
Hepatocyte, donor2	11603-120I1	960.99	10.77	1.08	4.31	1.08	1.08	4.31	0.00
Hepatocyte, donor3	11684-122I1	921.53	9.82	6.75	0.61	2.45	0.00	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1040.38	1.96	1.96	1.96	9.79	3.92	0.65	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	1251.79	5.07	1.05	4.02	2.62	1.40	0.70	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	761.77	1.10	0.41	1.51	0.82	0.82	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	901.04	0.00	0.00	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	607.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1300.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	664.50	0.00	0.00	0.00	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	553.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1174.96	11.87	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	791.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	530.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1021.70	0.00	0.00	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	561.88	1.67	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	588.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	918.49	0.00	0.00	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	596.45	0.00	0.00	0.00	0.00	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	670.50	0.00	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	662.62	1.26	0.00	0.63	0.63	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	564.52	1.55	0.00	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	468.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	810.13	0.00	0.00	0.00	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	709.98	0.00	0.00	0.00	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	979.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	809.17	0.81	0.00	0.81	0.81	0.00	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	326.19	0.42	0.00	0.42	0.00	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	747.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	759.48	0.00	0.00	0.80	1.61	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	483.80	0.92	0.00	0.00	1.85	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	844.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	542.84	0.94	0.94	0.94	1.89	0.94	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	497.93	0.91	0.91	2.72	0.91	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	987.74	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	751.13	0.00	0.00	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	628.88	1.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	624.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	699.53	0.64	0.00	1.28	0.64	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	657.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	1137.91	0.00	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	636.95	0.71	0.00	2.86	0.00	0.00	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	690.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	792.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	555.59	0.31	0.00	1.54	0.62	0.31	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	725.24	0.00	0.00	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	757.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	678.70	1.39	0.00	0.70	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	796.71	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	684.06	0.00	0.00	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	715.86	0.00	0.00	0.00	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	818.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	557.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	641.13	0.00	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	719.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	735.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	789.73	3.68	0.00	0.92	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	611.11	0.00	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	887.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	570.98	0.00	0.00	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	885.68	4.98	0.08	1.31	1.14	1.06	0.16	0.41
Keratinocyte - epidermal, donor2	11349-117G8	399.99	1.17	0.00	0.59	1.17	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	614.98	1.14	0.66	3.60	2.56	1.04	1.04	0.28
Keratinocyte - oral, donor1	11251-116E9	1141.99	5.45	1.82	3.75	1.48	1.59	1.14	0.79
Keratocytes, donor1	11527-119I6	395.41	0.00	0.34	0.69	0.34	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	380.84	0.00	0.00	2.34	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	682.90	2.37	0.59	1.98	0.40	0.99	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	5947.56	0.00	4.40	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	566.34	1.08	0.00	1.08	1.08	2.16	0.00	4.31
Lens Epithelial Cells, donor2	11609-120I7	1015.50	0.92	0.00	1.73	1.15	1.50	0.12	0.58
Lens Epithelial Cells, donor3	11690-122I7	1537.86	1.21	0.10	0.71	0.40	0.81	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	830.99	2.61	0.00	1.78	1.42	1.78	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	404.38	1.40	0.56	0.84	1.67	0.28	0.84	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	619.73	3.31	1.26	2.83	2.05	0.63	0.31	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	474.80	2.15	0.00	2.15	2.15	1.61	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	440.92	0.63	0.63	3.15	0.95	1.58	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	342.53	1.29	0.32	2.37	1.62	0.54	0.43	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	546.23	2.05	0.00	2.46	2.87	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	272.54	0.76	0.76	1.26	0.76	1.01	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	401.42	3.38	0.84	1.55	1.69	0.99	0.42	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	593.30	1.19	0.79	2.77	0.00	1.19	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	473.08	1.36	0.39	2.13	1.16	1.16	0.19	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	209.96	0.93	0.19	0.93	0.74	0.00	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	544.24	1.74	0.00	1.05	1.74	1.39	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	448.42	1.91	0.24	1.43	0.48	0.95	0.48	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	356.42	1.92	0.27	1.51	1.37	0.41	0.82	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	570.95	1.23	0.00	2.77	1.23	0.62	0.62	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	300.52	0.62	0.31	2.18	0.94	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	424.36	1.65	0.55	1.65	1.10	0.18	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	571.34	1.32	0.00	1.97	1.32	0.66	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	318.64	0.59	0.29	0.29	0.88	0.88	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	333.07	2.24	1.00	0.50	0.75	0.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	661.49	0.97	0.00	1.94	1.94	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	530.78	3.23	0.27	2.15	0.81	1.35	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	450.05	2.27	0.91	2.57	0.91	0.76	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	565.59	0.52	1.04	1.04	1.04	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	589.02	2.72	0.21	2.51	1.68	1.47	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	415.78	2.26	0.60	1.65	1.80	1.35	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	557.18	1.38	0.00	2.75	2.75	0.69	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	427.66	1.69	0.00	1.69	0.94	0.75	0.75	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	307.06	2.01	0.21	2.33	0.85	0.85	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	590.22	0.48	0.48	2.42	0.97	0.00	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	448.22	0.99	0.00	1.65	1.32	1.32	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	337.73	1.61	0.37	2.48	1.49	0.87	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	657.49	2.22	0.74	1.11	1.48	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	455.62	0.74	0.25	2.72	0.99	1.48	0.49	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	338.65	1.37	0.14	2.20	0.69	0.96	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	607.25	2.57	0.32	1.93	1.61	0.64	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	696.91	1.52	0.00	3.04	2.13	1.52	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	540.27	2.38	0.56	3.08	1.26	0.70	0.56	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	569.25	0.71	0.00	1.42	2.49	0.36	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	355.83	0.00	0.48	1.45	0.97	0.48	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	260.95	1.09	0.00	1.40	0.16	0.16	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	492.75	0.72	0.36	1.43	1.07	0.36	0.36	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	547.83	2.29	0.33	0.33	0.00	1.31	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	249.78	0.94	0.00	0.94	0.24	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	860.82	3.22	0.25	1.61	1.61	0.87	0.62	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	332.20	1.28	0.26	1.28	0.51	1.28	0.26	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	386.97	0.60	0.00	0.90	0.90	0.90	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	296.85	2.27	0.00	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	414.25	0.77	0.00	1.53	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	363.69	1.48	1.48	2.23	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	381.66	2.96	0.42	2.96	1.69	0.85	0.42	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	310.17	2.11	0.70	1.41	2.81	0.70	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	294.20	0.00	0.00	2.80	0.93	3.74	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	348.32	1.03	0.00	2.58	3.09	3.61	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	339.00	1.19	0.00	2.38	3.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	340.65	1.13	0.23	1.13	0.45	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	480.74	0.00	0.87	2.62	4.07	1.74	1.45	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	438.02	2.70	0.90	4.95	2.70	2.25	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	512.95	2.30	0.00	1.49	0.68	0.95	0.81	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	440.60	1.54	1.54	4.11	2.05	1.54	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	417.78	1.76	0.35	1.41	3.18	0.71	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	413.78	1.33	0.00	0.00	0.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	496.14	1.53	2.04	3.57	3.57	1.02	2.04	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	481.32	2.40	0.80	2.40	2.40	1.87	1.60	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	576.09	2.27	0.57	3.78	3.02	1.70	1.13	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	431.33	1.23	0.00	2.45	4.91	2.45	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	466.42	3.26	0.82	4.08	0.82	0.82	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	555.80	2.92	1.25	4.16	4.79	1.67	2.29	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	596.40	7.29	0.56	5.32	6.45	3.36	1.40	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	453.35	6.18	1.03	2.06	4.12	0.00	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	537.06	3.77	1.74	7.26	5.81	4.64	2.03	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	525.52	3.89	2.09	3.29	2.39	2.69	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	504.02	2.21	1.11	1.66	4.98	3.32	1.66	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	554.62	4.24	0.71	3.53	3.53	1.41	0.35	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	500.07	5.90	0.74	2.58	3.32	3.69	0.37	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	324.66	1.15	0.00	0.00	1.15	3.45	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	450.53	1.54	0.00	3.07	1.92	1.15	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	466.49	6.79	2.26	2.83	6.79	6.79	2.83	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	403.67	1.64	0.00	1.64	3.28	2.46	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	446.91	4.07	0.00	4.07	4.52	2.71	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	441.66	5.03	0.00	2.87	2.87	5.03	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	431.71	2.24	0.75	0.75	0.75	0.75	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	457.80	5.57	0.00	2.97	2.97	1.49	1.49	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	540.16	5.17	0.43	2.15	3.45	3.02	1.72	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	451.27	2.57	0.00	4.28	1.71	2.57	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	475.44	2.67	0.33	5.33	5.33	2.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	532.72	3.02	1.21	2.41	1.81	1.81	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	332.04	1.42	0.00	0.71	2.13	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	435.83	5.16	0.34	2.41	2.06	1.72	1.03	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	489.51	5.37	1.07	5.37	3.76	2.15	3.76	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	346.11	1.35	1.35	1.35	2.02	1.35	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	507.83	2.96	0.37	4.07	3.70	2.96	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	408.19	1.16	0.00	4.65	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	280.30	2.12	0.00	0.00	2.12	1.06	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	510.19	4.80	1.20	4.40	3.60	2.80	2.00	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	431.04	1.45	0.00	0.73	2.18	0.00	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	459.91	0.77	0.00	0.00	0.77	3.07	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	477.99	3.45	0.49	4.44	4.93	2.47	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	468.58	3.76	0.00	4.70	5.65	0.94	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	407.29	2.01	0.00	4.02	0.50	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	452.43	4.96	0.00	3.60	1.80	2.70	2.70	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	411.34	10.33	1.72	1.72	6.88	0.00	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	469.39	2.67	0.45	2.67	2.23	2.67	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	472.75	3.13	0.00	3.13	3.52	1.56	0.39	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	414.97	3.96	0.00	1.32	3.30	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	440.57	0.00	0.00	3.11	2.08	1.04	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	514.58	4.81	0.00	4.38	2.19	3.06	3.06	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	515.49	4.47	0.56	4.47	1.68	2.24	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	465.49	2.21	0.00	2.65	1.32	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	498.34	4.63	0.39	4.24	3.47	2.31	1.54	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	464.33	5.57	1.01	0.51	1.52	4.56	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	499.84	1.44	0.00	2.40	0.96	0.96	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	445.25	4.77	0.80	4.77	3.18	2.78	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	506.15	3.65	1.22	2.43	3.65	1.82	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	345.85	5.53	0.00	1.38	1.38	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	482.59	1.90	0.38	3.80	2.28	2.66	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	534.49	2.58	2.07	0.52	3.10	4.13	2.07	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	281.77	5.44	0.00	0.00	0.60	1.21	0.00	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	509.58	5.07	0.63	2.85	4.44	3.49	1.90	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	518.70	3.73	0.53	2.13	1.07	4.26	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	321.24	3.45	0.57	2.30	2.30	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	526.06	4.11	1.54	6.69	4.63	2.06	2.57	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	529.81	0.00	1.41	2.12	2.12	2.12	1.41	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	378.51	4.54	0.57	2.27	1.13	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	484.25	2.08	0.00	7.07	3.33	1.66	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	487.83	5.48	0.78	3.92	3.13	3.13	0.78	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	332.78	1.67	0.00	1.67	0.84	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	415.85	3.25	0.93	3.25	4.18	0.93	3.25	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	398.08	4.68	0.67	1.34	1.34	5.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	413.28	4.81	1.07	2.14	1.60	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	421.88	1.21	0.40	5.25	2.42	1.62	2.02	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	435.02	3.67	0.92	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	372.54	3.56	0.00	0.89	1.78	0.00	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	475.27	3.99	0.00	2.85	2.28	2.28	1.14	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	484.68	3.07	0.00	5.37	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	511.61	3.28	0.55	1.09	1.09	1.09	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	469.50	3.56	0.00	2.23	1.78	2.23	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	517.05	7.02	0.00	1.82	0.52	1.30	0.78	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	437.65	4.64	1.33	1.33	1.33	1.33	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	636.05	4.16	0.00	6.24	14.55	6.24	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	782.66	1.82	0.46	1.60	0.46	0.91	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	1237.02	2.94	0.00	2.39	1.28	1.28	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	833.94	2.10	0.66	3.80	1.05	1.18	0.52	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	517.75	1.59	0.00	1.06	0.00	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	1424.49	5.07	0.16	1.27	1.11	1.58	0.32	0.63
Mallassez-derived cells, donor3	11930-125I4	1351.51	2.92	0.00	1.25	1.11	1.25	0.83	0.28
Mammary Epithelial Cell, donor1	11273-116H4	1307.02	1.20	0.50	1.89	0.60	0.60	1.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	897.89	0.58	0.29	0.58	1.45	0.29	0.58	0.87
Mammary Epithelial Cell, donor3	11422-118F9	323.51	0.50	0.00	2.24	1.00	0.50	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	5495.35	42.71	0.00	19.66	0.00	5.42	0.00	1.36
Mast cell, donor1	11563-120D6	1417.94	10.71	1.19	1.84	0.65	0.97	0.22	1.19
Mast cell, donor2	11565-120D8	1112.92	9.51	2.67	1.78	0.30	0.00	0.30	0.59
Mast cell, donor3	11566-120D9	1601.76	5.18	6.75	1.58	0.23	1.35	0.00	1.13
Mast cell, donor4	11567-120E1	982.54	5.14	1.24	0.89	0.18	0.71	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	1631.12	7.32	1.22	3.33	1.66	1.00	0.78	1.44
Mast cell, expanded and stimulated, donor8	11942-126A7	1755.72	12.84	0.58	2.33	1.75	2.92	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	906.76	11.70	0.23	2.06	2.06	0.80	0.46	0.92
Mast cell, expanded, donor8	11941-126A6	1304.29	11.38	1.00	0.84	1.17	1.34	0.00	0.67
Melanocyte - dark, donor1	11502-119F8	642.26	1.79	0.20	0.70	0.70	0.60	0.20	0.30
Melanocyte - dark, donor2	11582-120F7	583.15	1.38	0.69	1.04	2.42	1.73	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	983.46	1.67	0.29	1.30	0.72	0.65	0.51	0.29
Melanocyte - light, donor1	11274-116H5	395.39	4.47	0.00	1.18	0.00	0.00	0.24	0.24
Melanocyte - light, donor2	11351-117H1	237.50	0.68	0.00	1.36	0.00	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	346.89	1.73	0.00	1.73	1.73	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	529.06	5.00	0.10	2.81	1.87	0.73	0.73	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	485.98	1.88	1.61	2.96	1.34	2.15	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	673.66	5.89	0.00	2.68	1.61	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	1537.72	1.86	0.00	0.37	0.00	0.50	0.12	0.00
Meningeal Cells, donor2	11573-120E7	1025.98	1.32	0.00	1.32	0.88	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	1889.21	3.42	0.16	3.10	1.96	2.20	0.57	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	933.89	0.86	0.00	1.71	0.86	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	1067.71	3.52	0.40	0.81	1.11	0.60	0.60	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	218.15	1.31	0.00	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	205.38	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	508.78	2.87	5.02	5.02	0.72	2.87	0.72	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	1128.51	9.11	0.64	1.91	0.64	1.06	1.06	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	961.56	6.53	0.00	1.51	2.51	1.51	1.01	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	628.71	0.44	0.00	1.32	0.44	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	578.63	0.00	0.00	1.46	0.00	0.00	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	476.72	1.02	0.00	0.61	0.00	0.20	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	776.33	1.52	0.14	1.11	1.25	0.42	0.14	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	273.22	0.00	0.00	0.37	0.37	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	892.73	1.84	0.00	1.58	0.92	2.11	1.18	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	375.67	0.30	0.00	0.00	0.30	0.30	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	235.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	418.18	1.92	0.00	0.00	0.00	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	841.10	2.13	1.06	1.06	1.06	1.42	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	605.12	1.88	0.00	2.50	0.63	1.25	0.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	630.63	0.73	1.45	1.45	4.35	0.73	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	1130.71	2.65	0.00	1.86	1.33	0.80	1.33	0.53
Mesothelial Cells, donor2	12156-128G5	952.39	0.50	0.00	0.00	0.00	1.00	0.00	1.50
Mesothelial Cells, donor3	11402-118D7	953.89	4.62	1.01	3.25	2.60	2.67	1.66	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	7290.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1786.23	2.22	3.45	2.22	2.46	1.48	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	1487.31	2.06	1.18	0.88	1.77	1.77	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	788.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1114.26	1.86	1.24	0.93	1.86	0.62	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	1030.11	2.90	0.83	2.28	2.90	2.07	0.41	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	1164.97	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	1273.83	3.75	0.25	0.75	1.00	1.25	0.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	1854.94	1.40	0.47	1.40	2.33	1.86	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	1596.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1091.67	2.03	0.61	1.22	2.64	1.22	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	1198.58	1.58	1.19	2.77	1.58	2.77	0.79	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	1701.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	685.83	2.65	0.88	2.65	1.77	1.77	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	959.34	2.28	0.76	3.42	3.80	2.66	1.14	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	814.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	818.34	2.55	0.42	1.70	3.18	2.12	0.85	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1336.12	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1092.97	3.28	2.38	2.38	2.38	0.60	0.60	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	2419.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	2342.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	823.46	1.76	0.50	2.51	1.76	3.76	0.50	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1118.46	2.38	0.95	2.38	2.38	2.14	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	706.03	0.55	0.55	0.00	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1013.54	0.69	0.23	2.76	2.07	0.92	0.92	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1136.25	2.31	0.42	1.89	1.05	0.84	1.05	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	979.80	3.06	0.41	1.43	0.20	2.04	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	917.80	0.64	0.86	1.93	2.57	2.15	0.00	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1401.99	1.11	1.11	0.89	1.78	1.78	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	722.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	906.29	1.31	0.44	1.53	1.31	1.53	0.44	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2054.69	0.51	0.00	0.51	1.01	0.00	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	901.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1511.71	1.63	1.63	2.17	0.82	0.54	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1350.72	1.18	1.18	1.18	1.47	1.76	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1368.36	0.00	1.09	0.00	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	672.78	0.96	0.96	0.96	1.44	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1105.43	1.20	1.60	4.00	4.00	4.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2054.08	0.00	6.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	774.39	1.50	0.50	0.00	0.50	1.50	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	889.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2299.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	826.80	1.31	0.00	0.44	0.44	1.31	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1989.89	1.10	6.62	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1417.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	932.42	0.99	0.25	1.74	1.49	1.24	1.24	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1441.20	0.00	0.70	0.70	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	1624.26	0.00	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	748.37	1.03	0.34	0.68	2.74	1.37	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1420.50	0.88	0.00	0.00	1.75	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1775.84	0.00	2.13	0.00	0.71	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	738.41	1.96	0.28	2.24	2.81	2.52	1.12	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1091.02	0.83	0.42	0.00	0.42	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1378.78	0.00	1.17	0.00	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	818.42	0.30	1.21	1.81	1.51	1.81	2.11	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1066.85	0.42	0.83	2.92	0.83	3.34	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	1956.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1025.15	1.85	2.77	2.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1305.56	1.71	0.57	0.57	0.00	0.57	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1285.09	0.55	0.28	0.69	0.28	0.83	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	707.22	1.81	0.52	2.59	2.59	1.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1503.13	3.43	2.14	3.43	0.43	1.29	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1087.45	0.00	0.00	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1116.40	0.53	1.87	0.53	1.33	0.80	0.53	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	1251.80	3.29	1.50	0.60	1.20	2.10	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	987.79	0.99	0.57	1.27	0.42	1.27	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	621.42	0.96	0.32	0.64	1.27	0.64	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1103.00	0.66	0.88	0.88	0.22	0.44	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1033.32	0.76	0.00	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	966.53	1.14	1.42	1.42	1.14	2.56	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	771.58	2.95	0.49	2.21	1.23	0.49	0.25	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1423.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	1049.09	1.47	1.47	1.47	0.88	1.47	0.59	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	1016.64	3.46	0.58	1.15	0.86	2.02	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2362.00	2.47	4.95	1.24	0.41	1.65	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	890.07	0.89	0.60	0.60	0.30	0.89	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	237.31	0.00	0.00	0.00	0.00	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	516.85	0.00	1.78	0.00	3.56	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	822.09	1.97	1.31	2.63	3.94	1.31	1.31	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	594.35	1.05	1.05	6.31	3.16	3.16	3.16	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	922.41	0.99	0.00	1.78	1.98	1.19	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	861.47	1.86	0.00	3.73	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	842.31	1.88	1.13	1.88	0.38	0.75	0.38	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	680.24	0.53	0.27	2.40	1.07	1.07	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	767.96	1.02	0.00	0.90	0.57	0.68	0.11	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	631.37	1.47	0.00	2.21	2.21	1.47	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	773.52	2.93	0.73	2.93	2.56	1.47	0.37	2.93
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	794.91	6.22	0.00	4.67	15.56	10.89	3.11	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1239.36	1.07	0.00	1.07	0.00	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	463.67	0.00	0.00	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	676.66	4.04	0.00	3.03	1.01	2.02	1.01	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1151.08	1.26	1.26	3.37	1.69	3.37	0.84	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1334.70	2.72	0.00	1.36	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	364.31	0.00	0.00	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	379.00	0.00	0.00	0.00	0.81	0.00	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1386.58	7.55	21.15	1.51	6.04	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	913.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	1706.26	0.00	0.00	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	836.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	828.24	0.00	150.59	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	1215.71	2.37	0.00	2.37	2.15	1.29	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	1067.17	5.23	1.05	4.18	1.57	2.61	0.52	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	1233.52	0.00	23.36	0.67	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	1272.15	0.00	1.25	0.42	0.83	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	5742.47	2.09	0.38	2.85	1.71	1.33	0.95	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	8548.98	3.19	17.55	1.60	0.00	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	630.31	0.68	9.52	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	2504.71	0.00	0.00	9.19	0.00	9.19	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	617.34	1.67	9.21	1.26	0.84	0.84	0.00	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	1442.75	0.23	3.02	1.86	0.23	0.46	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	1287.36	1.08	8.11	1.89	0.54	1.89	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	2101.32	2.31	13.46	2.10	0.42	1.26	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2171.27	33.40	11.13	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	500.33	0.50	6.95	2.48	1.49	0.50	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	1511.69	1.62	0.54	1.08	0.54	0.54	0.54	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	693.42	2.04	5.21	1.36	0.68	0.00	0.23	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	1325.03	0.33	3.59	1.47	0.16	0.65	0.16	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	1399.17	2.55	8.57	2.92	0.73	2.55	0.91	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	583.48	1.06	11.14	1.59	1.06	0.53	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	497.65	1.80	12.61	1.80	0.60	1.20	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4976.15	4.27	1.64	0.66	1.31	0.66	0.66	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	911.99	0.98	5.85	0.65	0.33	0.00	0.49	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	2752.44	3.17	36.51	1.41	0.88	1.06	0.88	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	548.52	2.81	7.03	3.52	0.00	0.70	0.00	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	713.01	0.92	2.76	0.46	0.92	0.92	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	733.63	1.29	5.46	1.61	1.29	0.96	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	4186.60	5.52	0.00	7.59	4.83	2.41	0.34	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	8002.53	7.59	0.00	12.64	5.06	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	2321.86	1.11	14.48	1.11	0.22	0.45	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	786.66	0.42	9.31	2.12	0.85	2.12	0.85	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	1448.56	2.61	1.90	1.66	0.24	0.00	0.00	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	555.88	0.00	4.29	0.86	2.15	1.72	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	3909.02	18.06	0.00	18.06	9.03	27.08	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	862.38	2.33	4.00	1.00	0.33	2.33	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	3005.00	0.90	18.03	1.35	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	522.59	0.79	4.36	2.38	0.40	1.19	0.00	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	624.05	1.86	18.57	0.00	0.93	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	806.69	1.14	0.76	1.51	0.38	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	783.76	1.30	8.47	3.58	0.98	1.63	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	902.51	0.87	8.72	0.00	0.87	0.87	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	3490.30	3.62	23.07	3.17	0.45	1.36	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	667.61	0.88	8.82	1.76	0.88	1.76	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	499.96	2.66	8.64	0.66	1.33	0.00	1.33	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	601.20	1.98	6.94	2.98	0.00	1.98	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	890.84	0.00	12.63	1.15	1.15	0.77	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	767.00	0.60	0.60	1.51	0.91	0.30	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	1954.73	1.77	10.17	2.21	1.33	1.11	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	484.52	0.68	7.45	4.07	0.68	2.03	0.68	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	2033.59	5.11	0.00	10.22	5.11	5.11	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	407.88	0.61	5.49	2.44	0.61	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	895.42	0.31	4.09	0.63	0.31	1.57	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	1134.65	0.30	7.57	0.91	0.61	0.00	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	508.70	0.79	11.87	4.75	0.79	1.58	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	4975.56	7.94	1.13	4.53	0.00	4.53	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1906.82	0.00	0.00	5.06	5.06	10.12	5.06	5.06
Myoblast, donor1	11241-116D8	802.89	3.23	0.12	4.22	1.37	1.24	0.87	1.37
Myoblast, donor2	11322-117D8	826.22	2.11	0.96	6.90	2.30	2.69	1.73	0.38
Myoblast, donor3	11398-118D3	1346.98	2.52	0.17	2.02	1.18	2.02	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	717.55	1.02	2.63	1.61	1.02	0.44	0.44	0.58
Natural Killer Cells, donor1	11230-116C6	1568.95	4.61	4.00	1.85	3.69	1.54	0.00	1.85
Natural Killer Cells, donor2	11311-117C6	1067.81	4.52	6.33	6.03	7.24	3.02	3.02	1.21
Natural Killer Cells, donor3	11387-118C1	1009.54	3.13	4.42	3.87	2.58	1.47	1.47	1.29
Neural stem cells, donor1	11275-116H6	2578.69	58.07	0.00	4.72	1.81	5.44	0.00	1.09
Neural stem cells, donor2	11352-117H2	2907.72	25.03	0.00	1.93	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	1959.46	5.69	3.41	11.38	6.83	6.83	4.55	0.00
Neurons, donor2	11574-120E8	1799.39	8.37	0.22	5.72	1.76	2.20	2.20	1.10
Neurons, donor3	11655-122E8	2510.07	5.76	8.22	25.49	8.22	10.69	4.93	3.29
Neutrophils, donor1	11233-116C9	1350.25	14.85	1.86	2.78	6.50	0.93	1.86	4.64
Neutrophils, donor2	11314-117C9	1078.38	11.60	5.80	17.39	26.09	14.49	5.80	8.70
Neutrophils, donor3	11390-118C4	2884.40	18.33	1.83	4.89	1.83	1.83	0.61	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	1042.97	3.56	0.12	1.42	1.31	0.47	0.83	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	471.80	1.63	0.33	1.95	1.95	0.98	0.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	609.88	1.80	0.60	0.80	1.20	1.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	1167.84	3.44	2.48	3.30	1.65	1.93	0.55	1.51
Olfactory epithelial cells, donor2	11934-125I8	1413.29	5.07	1.88	15.92	8.54	5.50	4.05	1.74
Olfactory epithelial cells, donor3	11935-125I9	1052.53	1.93	2.04	3.06	1.25	1.82	0.57	0.79
Olfactory epithelial cells, donor4	11936-126A1	1397.46	2.14	0.58	1.46	0.68	1.75	0.68	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	1138.64	3.61	0.00	1.81	0.60	0.00	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	809.94	7.44	0.43	0.43	0.21	0.64	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	212.62	6.86	1.14	2.29	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	271.25	1.86	1.24	1.24	1.24	1.24	1.24	0.00
Osteoblast, donor1	11277-116H8	938.68	2.93	0.20	1.17	0.20	0.39	0.20	0.39
Osteoblast, donor2	11354-117H4	1649.04	1.40	0.00	2.11	2.81	2.81	0.00	0.70
Osteoblast, donor3	11426-118G4	849.91	2.49	0.18	3.91	0.89	1.24	0.89	0.89
Pancreatic stromal cells, donor1	11249-116E7	1294.45	13.81	0.42	4.13	1.60	1.26	1.10	0.84
Pericytes, donor1	11491-119E6	238.44	0.22	0.11	0.11	0.11	0.22	0.00	0.00
Pericytes, donor2	11571-120E5	293.60	0.68	0.68	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	358.68	1.22	0.61	0.61	1.22	0.41	0.41	0.41
Perineurial Cells, donor1	11499-119F5	1096.87	1.47	0.34	1.47	0.90	0.34	0.57	0.45
Perineurial Cells, donor2	11579-120F4	896.83	2.58	0.00	0.92	1.01	0.28	0.37	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1561.82	3.82	2.23	0.64	0.32	0.64	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	886.65	5.39	0.73	5.39	5.14	2.20	1.71	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	907.20	2.98	1.42	2.72	2.07	1.81	0.52	0.39
Placental Epithelial Cells, donor1	11278-116H9	893.05	4.30	0.24	0.72	0.24	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	553.33	1.11	0.00	1.11	0.00	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	344.75	1.57	0.20	1.77	1.37	0.98	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	501.58	3.80	0.32	6.65	5.70	2.22	0.63	2.22
Preadipocyte - breast, donor1	11467-119B9	1151.79	8.07	0.19	1.13	1.88	0.94	0.19	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	877.01	0.65	1.04	0.65	1.04	0.78	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	733.76	3.38	0.45	8.56	4.95	3.38	2.25	1.58
Preadipocyte - omental, donor1	11468-119C1	1229.26	8.52	0.43	1.81	1.07	2.24	1.07	0.96
Preadipocyte - omental, donor2	11329-117E6	1510.62	6.55	0.00	2.62	3.06	0.87	0.00	2.18
Preadipocyte - omental, donor3	11403-118D8	1039.98	4.15	0.72	5.01	2.44	2.01	2.01	2.15
Preadipocyte - perirenal, donor1	11469-119C2	391.74	0.98	0.00	0.98	1.97	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	621.30	2.15	0.00	0.61	0.31	0.61	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	1280.62	5.67	0.89	8.32	8.50	5.31	3.54	1.95
Preadipocyte - subcutaneous, donor3	11428-118G6	666.49	11.07	0.00	2.89	2.55	1.87	1.36	0.17
Preadipocyte - visceral, donor1	11280-116I2	1676.56	8.38	0.19	0.84	0.75	1.68	0.47	0.65
Preadipocyte - visceral, donor2	11357-117H7	1125.14	15.19	0.92	7.82	7.36	5.52	1.84	2.30
Preadipocyte - visceral, donor3	11429-118G7	787.65	5.85	0.52	1.88	3.45	1.57	1.88	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	1160.96	26.55	1.51	3.62	1.51	1.06	0.91	1.51
Prostate Epithelial Cells, donor2	11331-117E8	681.27	12.59	0.41	3.11	5.42	2.84	1.22	0.95
Prostate Epithelial Cells, donor3	11404-118D9	426.46	6.06	0.86	1.90	1.35	1.04	0.31	0.37
Prostate Stromal Cells, donor1	11254-116F3	1103.13	4.21	0.00	3.99	1.82	1.37	0.80	1.03
Prostate Stromal Cells, donor2	11332-117E9	1114.34	4.12	0.72	5.74	4.84	3.41	2.51	1.43
Prostate Stromal Cells, donor3	11405-118E1	611.37	7.09	0.10	2.71	3.23	2.19	0.94	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	367.90	0.73	0.00	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	823.98	2.08	0.14	1.04	2.08	1.32	0.55	0.42
Renal Epithelial Cells, donor1	11517-119H5	324.63	0.51	0.00	0.00	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	280.26	0.00	0.00	0.71	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	982.00	1.80	0.32	2.22	1.48	1.27	0.32	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	260.09	1.36	0.00	1.36	0.00	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	559.95	1.48	0.54	0.94	0.27	0.94	0.27	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	1783.64	2.44	0.67	3.11	1.55	2.22	2.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	247.54	0.67	0.00	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	443.70	2.20	0.00	0.22	0.44	0.22	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	336.69	2.51	0.00	1.25	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	142.03	0.55	0.00	0.00	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	784.87	0.54	0.00	0.54	0.00	0.54	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	331.03	1.69	0.42	0.84	0.42	0.84	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	385.31	0.96	0.58	1.35	0.39	0.77	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	891.41	1.30	0.52	2.33	0.52	1.04	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	795.88	1.14	0.28	0.57	0.28	0.57	0.00	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	270.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	1105.75	7.03	0.50	2.01	0.50	2.01	0.50	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	1686.75	17.51	1.47	1.47	0.94	0.80	0.40	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	805.85	3.57	6.25	1.79	0.89	0.89	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1564.15	18.71	6.05	3.85	0.55	1.10	0.00	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1475.66	7.54	24.94	3.48	0.58	2.32	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	2080.66	2.99	1.43	1.04	1.30	1.04	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	984.22	2.88	2.98	2.98	0.99	2.68	0.79	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	1001.40	2.90	0.45	1.90	0.67	1.00	0.67	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	999.66	4.47	0.87	2.11	1.61	1.98	1.12	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	944.13	3.50	1.86	5.01	1.98	2.68	1.28	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	1072.45	4.62	3.24	4.85	2.31	1.39	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1136.48	2.60	3.42	0.96	1.37	1.10	0.96	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	873.30	2.27	1.51	3.18	2.27	1.21	0.76	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	980.89	1.97	0.18	1.43	1.08	1.08	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	952.84	3.73	2.15	0.57	1.43	1.00	0.43	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	864.52	2.68	0.75	2.36	3.11	1.18	0.54	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	908.09	3.54	1.55	2.21	0.66	0.66	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1404.38	2.49	5.93	1.34	0.96	1.53	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	1130.07	2.33	2.52	2.42	0.75	0.84	0.19	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	1401.79	6.95	1.13	1.13	0.56	1.50	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	1488.84	2.26	5.97	0.93	1.46	0.53	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	1092.94	3.80	2.24	3.11	1.65	2.04	0.29	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	941.43	5.16	3.06	2.48	0.76	1.53	1.34	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	1189.57	2.14	3.63	0.75	1.07	1.28	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	938.18	4.77	2.80	2.52	2.80	3.92	1.96	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	1179.71	3.76	1.03	2.39	0.68	1.03	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	1320.25	3.10	3.46	1.09	1.46	1.09	0.91	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	985.60	3.31	1.84	2.08	1.96	1.23	0.98	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	797.73	3.22	0.54	3.22	1.75	0.94	1.48	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	1163.32	3.30	2.36	1.89	1.42	0.71	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	1058.54	2.18	1.79	2.38	2.58	1.39	0.99	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	942.17	3.04	1.40	4.44	0.47	0.47	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	1061.87	4.15	0.83	1.87	1.45	0.62	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	1203.38	4.87	2.43	5.97	3.54	3.76	1.11	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	1107.09	3.34	1.67	2.09	1.67	1.25	0.21	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	1155.14	3.77	4.17	1.88	1.88	1.08	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	1562.80	3.41	5.28	1.19	1.02	1.36	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	1183.95	3.08	4.82	2.89	1.35	1.54	0.39	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1166.60	3.95	1.89	1.20	1.72	1.38	0.86	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	1331.22	2.33	3.29	1.37	0.14	1.78	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	1243.25	4.27	4.43	6.07	2.63	2.79	1.31	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1153.47	2.39	2.73	0.00	1.36	1.19	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	950.03	5.18	2.22	2.66	0.30	0.15	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	1182.42	2.40	2.40	2.93	0.27	1.33	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	790.47	3.46	2.49	0.41	0.83	1.80	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	615.97	4.05	0.71	2.86	1.19	0.48	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	1461.17	3.22	6.05	1.21	0.40	0.20	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	594.33	5.84	0.47	0.38	1.13	0.94	0.09	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	659.25	4.89	5.24	1.05	1.75	1.05	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	838.04	2.42	5.14	3.32	0.60	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	657.95	12.12	0.98	2.08	0.73	0.86	0.37	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	979.42	4.95	1.02	2.04	0.87	1.16	0.15	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	574.96	5.48	1.22	0.61	0.00	0.61	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	727.28	8.44	1.81	0.90	0.90	0.60	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	566.15	13.35	3.62	1.81	0.68	1.36	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	630.23	5.39	1.80	2.40	1.50	1.80	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	713.17	16.77	1.06	0.83	0.35	0.35	0.47	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	514.19	21.98	0.43	3.20	1.07	2.99	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	711.56	15.02	3.00	4.21	2.40	3.00	0.60	1.20
Schwann Cells, donor1	11498-119F4	328.56	0.38	0.38	0.75	0.00	0.00	0.38	0.19
Schwann Cells, donor2	11578-120F3	721.31	0.00	0.00	3.40	0.00	3.40	0.00	3.40
Schwann Cells, donor3	11659-122F3	844.34	1.97	1.97	4.60	2.85	2.85	0.88	0.44
Sebocyte, donor1	11220-116B5	1293.28	10.96	0.00	0.55	1.64	0.55	0.00	0.55
Sebocyte, donor2	11301-117B5	844.66	5.06	0.00	3.22	2.76	1.38	0.92	1.38
Sebocyte, donor3	11378-118B1	411.19	1.86	0.00	2.06	1.24	1.03	0.00	0.00
Sertoli Cells, donor1	11255-116F4	990.65	19.88	0.00	4.97	1.66	1.66	0.00	1.66
Sertoli Cells, donor2	11333-117F1	762.58	2.82	0.00	5.65	11.30	5.65	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	1376.24	16.36	0.18	1.67	0.26	1.23	0.70	0.70
Skeletal Muscle Cells, donor2	11358-117H8	255.16	2.17	0.72	1.45	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	710.63	5.02	0.84	0.84	2.51	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	777.77	2.98	0.79	1.10	1.89	1.26	0.47	0.16
Skeletal Muscle Cells, donor5	11455-119A6	754.97	2.08	0.30	2.97	2.08	1.34	1.19	0.45
Skeletal Muscle Cells, donor6	11459-119B1	990.05	1.54	0.62	2.62	2.31	1.54	0.15	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	912.28	3.78	0.13	2.39	1.51	0.50	1.01	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	638.67	2.28	0.43	3.42	1.85	1.43	0.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	919.68	1.79	0.89	3.97	2.48	0.89	1.49	1.39
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	1789.76	7.41	0.59	1.26	1.26	0.51	0.34	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	665.86	2.17	0.00	2.90	0.72	0.00	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	491.23	0.83	1.51	1.38	1.51	1.79	0.28	0.14
Skin - palm, donor1	10286-104F7	1474.67	0.00	128.93	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	422.52	2.02	0.14	2.16	1.59	1.30	0.14	1.01
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	1198.21	0.00	13.90	3.27	0.82	1.64	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	449.72	2.34	0.00	2.21	2.21	1.56	0.52	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	1146.54	12.51	0.14	3.06	2.92	2.22	1.25	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	1525.71	6.75	3.94	4.36	2.81	1.55	0.84	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1013.25	1.27	4.86	0.63	0.21	0.63	0.42	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	1059.28	6.75	5.47	2.55	1.65	1.87	0.60	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	810.65	6.48	0.00	2.78	7.10	2.78	1.54	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	576.95	2.22	1.33	0.67	0.89	0.89	0.00	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	891.15	1.76	0.00	0.59	0.59	1.76	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	959.10	2.43	0.00	3.54	1.10	1.10	0.66	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	849.78	2.36	0.00	1.18	0.39	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	1022.11	1.55	0.00	1.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	768.58	7.01	1.00	2.00	4.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	1012.32	5.99	0.13	1.33	0.40	0.13	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	622.63	2.88	1.55	3.32	3.77	1.77	1.11	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1300.66	4.61	1.66	2.18	1.79	1.92	0.38	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	694.48	0.98	0.33	0.33	0.00	0.65	0.98	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	1009.72	1.48	0.00	2.66	0.30	0.30	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	530.31	1.00	0.00	1.14	0.71	1.42	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	213.92	0.16	0.16	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	1142.84	2.13	0.91	2.44	1.52	2.44	0.61	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	687.73	2.78	0.00	0.00	0.51	0.25	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	1034.40	0.00	0.00	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	435.83	1.91	1.91	0.95	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	645.94	2.21	0.15	1.77	0.59	0.29	0.29	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	537.02	1.94	0.86	2.58	3.23	1.72	0.86	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	555.12	1.57	0.21	2.52	1.26	1.05	0.63	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	1074.71	2.63	0.15	1.24	0.00	0.46	0.46	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	479.66	3.23	0.00	3.23	0.00	2.16	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	587.85	2.39	0.00	0.90	1.20	0.30	1.20	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	286.78	0.34	0.00	0.00	0.00	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	803.90	2.04	0.24	2.83	1.10	1.33	0.71	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1430.31	28.78	0.50	2.42	0.91	1.51	0.91	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	620.08	2.96	0.91	5.01	2.50	1.14	0.68	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	380.40	1.81	0.60	2.42	0.60	0.60	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1741.36	2.38	0.00	5.56	1.85	1.06	1.06	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1507.10	7.59	0.53	0.67	0.80	0.80	0.13	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	810.05	8.89	1.13	4.88	2.75	2.13	0.75	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	763.27	4.06	0.25	0.51	0.25	0.25	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	1611.16	7.39	0.15	1.21	0.75	1.36	1.06	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	516.12	3.00	0.00	5.25	2.25	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	4232.00	18.09	0.00	2.58	3.88	2.58	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	926.89	0.93	0.00	1.86	0.47	0.47	1.40	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	604.34	3.53	1.01	1.01	1.01	2.02	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	533.71	2.51	0.00	3.45	0.94	2.51	1.25	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	209.15	0.00	0.00	0.00	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1921.80	0.83	0.83	0.75	0.67	0.58	0.17	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	871.72	1.40	1.40	2.34	1.40	1.87	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	961.66	2.88	0.00	1.01	0.14	0.29	0.58	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	652.18	3.57	0.76	4.33	1.27	0.76	1.78	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	635.18	3.38	0.38	2.07	2.07	0.56	0.38	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	1281.04	1.96	0.00	1.54	1.12	1.26	0.42	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	904.74	1.26	0.00	0.50	0.50	0.84	0.59	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	107.14	0.48	1.43	0.95	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	699.49	4.65	0.00	1.47	0.73	0.98	1.47	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	1604.08	10.16	0.22	1.55	1.55	0.66	0.44	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	968.14	3.80	1.17	1.76	0.59	2.05	0.59	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	1588.12	7.58	0.58	1.36	0.58	0.97	0.78	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	1027.93	2.91	1.85	2.91	2.64	1.32	0.53	1.85
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2251.77	22.32	1.86	4.09	3.72	3.72	3.35	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	1504.18	6.47	0.72	4.67	3.23	1.44	1.44	3.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1036.52	2.84	0.85	1.14	0.57	1.14	0.85	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1898.84	3.54	1.18	3.54	1.97	2.36	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	1422.38	9.65	1.52	3.81	4.32	7.36	3.05	3.81
Smooth muscle cells - airway, control, donor2	11967-126D5	1270.23	7.99	1.20	1.20	2.00	1.20	1.60	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	1166.23	7.52	0.00	4.60	3.76	2.09	1.67	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	1034.06	4.58	0.00	1.38	2.29	1.83	0.92	0.92
Synoviocyte, donor1	11291-117A4	1104.86	6.40	0.84	2.36	1.85	1.51	0.67	1.68
Synoviocyte, donor2	11368-117I9	508.57	3.86	1.34	2.85	1.51	0.84	0.84	1.01
Synoviocyte, donor3	11440-118H9	542.66	3.80	0.89	1.12	2.68	0.22	0.89	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	604.96	0.36	0.00	0.36	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	275.50	0.00	0.00	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	422.57	0.46	0.23	0.93	0.46	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	1242.00	5.23	0.65	0.72	0.50	1.08	0.65	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	332.44	1.16	0.00	1.16	0.77	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	432.36	2.86	0.57	1.15	1.15	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	1727.88	16.61	0.86	1.85	0.86	0.98	0.25	0.37
Urethra, donor2	10319-105A4	2524.99	8.99	219.41	5.40	0.00	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	376.97	1.59	0.00	0.53	0.27	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	264.77	1.20	0.80	1.60	0.40	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	220.72	0.46	0.23	0.69	0.92	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	987.43	2.45	0.45	2.90	0.45	1.56	1.78	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	1562.46	2.67	1.78	0.00	0.00	0.89	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	1646.91	1.43	1.43	2.86	0.00	1.43	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	717.38	1.37	0.00	6.16	2.74	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	1254.08	1.03	1.03	0.69	1.38	0.69	0.34	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	1113.25	1.16	0.00	1.74	1.16	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	1556.65	0.00	1.04	2.08	2.08	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1458.37	0.00	0.00	0.00	0.00	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	698.37	2.74	0.00	3.65	2.74	1.83	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	1249.53	1.97	2.59	2.59	2.22	2.96	1.73	0.25
Wilms' tumor cell line:HFWT	10597-108E3	2044.33	0.88	20.24	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	654.16	1.12	6.42	1.40	0.56	0.28	0.56	0.56
achilles tendon, donor2	10292-104G4	1037.40	4.13	121.93	0.00	2.07	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1077.44	1.02	3.06	1.78	1.27	0.76	0.76	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	2154.81	2.09	4.18	1.39	0.70	0.70	0.70	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1310.30	2.37	2.85	1.90	1.54	1.42	0.59	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2368.48	3.27	4.08	3.27	2.18	2.99	1.63	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1029.33	2.25	2.25	5.62	2.53	3.94	1.41	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	734.90	1.06	0.00	1.48	0.85	0.85	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	856.92	2.99	11.16	1.91	0.82	1.63	0.54	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1171.22	3.08	4.41	2.64	0.88	1.76	0.88	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	785.68	2.45	5.72	0.41	3.27	3.68	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1244.88	0.39	8.54	3.11	3.11	1.55	1.16	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1199.50	1.84	1.47	5.15	2.02	2.58	0.55	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	1150.65	3.90	374.45	0.00	3.90	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1067.79	1.39	2.56	3.25	2.09	1.16	1.86	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1451.92	1.29	0.52	6.47	2.85	2.33	1.81	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1189.73	3.21	4.09	4.68	1.75	1.17	1.46	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	645.55	0.46	16.73	0.00	0.00	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1169.19	1.23	4.52	4.11	0.00	3.29	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1149.84	1.23	0.61	1.23	0.00	1.23	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1657.34	2.13	0.43	2.99	0.43	0.43	2.56	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1308.41	1.21	1.52	1.82	1.82	2.73	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1700.10	2.65	0.72	1.44	1.44	1.20	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1134.18	2.23	0.67	3.56	2.00	2.90	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	2474.25	3.34	9.34	2.00	1.33	1.67	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9419.23	0.00	39.02	3.72	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1607.21	2.64	4.52	3.01	3.01	2.26	2.26	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1856.18	0.00	15.26	1.31	0.87	2.62	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	6924.27	1.87	35.61	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	1386.15	1.18	11.07	1.18	1.18	1.65	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	1058.84	23.42	0.16	2.64	0.31	1.24	0.31	0.47
adipose, donor1	10184-103D4	3956.50	100.28	0.59	6.45	4.69	2.35	2.93	2.35
adipose, donor2	10185-103D5	1787.93	17.84	15.00	5.27	0.81	0.81	0.41	2.84
adipose, donor3	10186-103D6	2205.81	21.24	1.63	4.63	1.91	2.18	0.82	3.00
adipose, donor4	10187-103D7	3963.66	20.80	3.47	14.73	1.73	4.33	4.33	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1397.65	0.47	7.26	1.42	0.63	0.63	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	676.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	553.50	4.00	0.27	0.67	0.53	0.67	0.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1254.48	2.14	6.07	1.79	0.00	0.71	1.79	0.71
amniotic membrane cells, donor1	12235-129G3	1599.76	4.64	0.00	2.09	2.32	1.85	1.16	0.93
amniotic membrane cells, donor2	12236-129G4	1230.70	9.80	0.68	3.04	0.68	1.35	1.69	2.03
amniotic membrane cells, donor3	12237-129G5	1237.03	2.36	1.77	2.95	2.65	3.24	1.18	0.29
amygdala - adult, donor10196	10167-103B5	1445.49	4.74	0.00	3.56	0.00	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	1126.37	3.45	1.82	2.64	2.23	2.84	0.41	1.01
amygdala, newborn, donor10223	10360-105E9	1405.34	1.61	2.90	0.97	0.32	1.29	0.32	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	814.27	8.28	0.64	1.40	0.64	0.76	0.51	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1172.61	0.66	2.87	4.41	1.99	1.99	0.88	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1842.21	1.34	31.07	3.67	2.34	1.34	2.00	1.67
aorta, adult, pool1	10052-101G7	1017.93	2.35	0.78	3.73	1.96	1.96	0.78	0.20
appendix, adult	10189-103D9	1345.22	10.09	8.15	1.55	1.94	1.55	0.78	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1031.12	3.44	8.94	3.10	1.38	1.03	0.34	0.34
artery, adult	10190-103E1	832.88	20.38	17.66	1.36	0.00	1.36	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	1713.92	4.20	1.59	0.87	0.58	0.72	0.43	1.16
b cell line:RPMI1788	10427-106D4	702.76	1.64	1.64	0.59	0.74	0.30	0.45	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	1478.52	4.72	0.83	4.72	4.44	4.16	2.22	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	1242.68	4.47	0.10	0.89	0.79	0.89	0.60	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	1152.57	1.67	3.35	0.67	1.34	0.33	0.50	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	518.97	1.68	1.68	2.24	0.56	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	1400.60	10.86	0.65	1.85	1.09	0.87	0.22	0.54
blood, adult, pool1	10053-101G8	679.89	2.21	6.64	6.64	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	4861.48	0.86	5.14	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	1017.64	8.77	2.70	3.37	1.35	2.70	0.67	2.02
brain, adult, donor1	10084-102B3	510.48	3.08	2.05	4.10	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	944.43	13.92	0.33	1.56	0.89	1.11	0.78	0.45
brain, fetal, pool1	10085-102B4	1584.14	2.67	0.00	2.67	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	1280.16	2.97	59.80	1.32	0.99	0.66	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	1384.41	1.00	5.74	0.37	0.25	0.25	0.25	0.12
breast, adult, donor1	10080-102A8	1299.33	8.84	3.16	0.63	0.00	2.53	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1837.22	1.02	3.30	4.32	2.29	1.78	1.14	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	1358.10	0.93	18.86	0.93	0.31	1.86	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1046.81	1.61	0.46	3.22	3.68	3.45	1.84	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	525.33	1.21	7.26	0.73	0.00	0.97	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	704.31	2.35	11.28	2.82	0.94	0.94	0.47	1.41
carcinoid cell line:NCI-H727	10735-110B6	1538.22	1.31	4.92	1.53	1.20	1.64	0.33	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	572.63	0.63	2.85	1.27	0.95	0.95	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	1781.53	5.59	13.58	5.59	2.93	3.19	1.33	0.53
caudate nucleus - adult, donor10196	10177-103C6	1471.39	3.45	1.15	2.30	1.15	1.15	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	834.29	2.84	0.67	4.02	1.67	1.84	1.67	1.17
caudate nucleus, adult, donor10258	10379-105H1	738.92	3.06	1.53	0.76	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	1519.14	4.76	1.46	1.10	1.46	1.10	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	1611.04	8.74	8.74	2.91	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	1361.13	11.53	3.20	4.27	1.07	1.92	0.85	1.49
cerebellum, adult, pool1	10083-102B2	485.68	4.48	2.41	2.41	0.34	1.38	0.34	1.03
cerebellum, newborn, donor10223	10357-105E6	2009.30	5.81	10.79	2.49	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	1244.31	6.56	1.26	2.02	0.25	2.27	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	1732.93	1.46	27.77	1.46	1.46	4.39	0.00	2.92
cervical cancer cell line:D98-AH2	10552-107I3	739.90	2.16	0.72	0.29	0.29	0.29	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	2143.54	4.47	1.16	1.82	0.99	0.83	0.83	0.66
cervix, adult, pool1	10013-101C4	1612.23	17.32	1.36	1.99	1.26	0.63	0.52	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	865.57	2.09	0.84	0.98	0.70	0.28	0.28	1.53
chondrosarcoma cell line:SW 1353	10700-109G7	3008.31	0.00	2.61	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1649.14	34.55	1.74	4.60	2.11	2.36	1.12	1.49
choriocarcinoma cell line:SCH	10785-110H2	1219.19	1.48	3.82	2.59	2.09	1.72	1.36	1.11
choriocarcinoma cell line:T3M-3	10618-108G6	1586.48	2.85	15.89	0.00	0.00	0.47	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	1081.84	5.70	0.28	3.13	6.27	1.71	1.14	1.14
chorionic membrane cells, donor2	12239-129G7	1194.77	18.30	0.10	1.79	2.49	2.19	0.70	1.39
chorionic membrane cells, donor3	12240-129G8	1066.55	23.08	1.65	4.95	7.14	3.85	5.49	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	777.55	4.04	0.00	5.05	13.13	6.06	0.00	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1244.03	0.58	1.73	3.65	1.54	1.73	1.34	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1738.70	2.32	13.09	3.17	1.69	1.69	1.06	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1099.11	0.77	2.31	0.26	1.03	1.80	0.00	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1317.75	0.48	4.35	1.94	1.45	0.73	0.24	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1322.04	3.26	2.24	2.24	1.22	1.83	0.61	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	2180.44	2.06	2.65	1.77	1.47	1.77	0.59	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	3018.04	3.65	2.61	2.09	0.52	1.04	0.52	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	477.05	3.43	2.06	2.29	3.66	1.83	0.91	0.91
clear cell carcinoma cell line:TEN	10636-108I6	1571.27	1.74	1.56	2.60	2.43	1.04	1.21	0.69
colon carcinoma cell line:CACO-2	10513-107D9	2378.81	4.58	2.01	2.20	0.73	2.01	1.28	1.65
colon carcinoma cell line:COLO-320	10420-106C6	1494.10	0.76	0.00	2.66	0.76	1.90	0.38	1.14
colon, adult, donor1	10082-102B1	948.46	0.00	0.00	1.19	2.38	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	1530.72	13.87	1.76	0.71	1.06	0.00	0.12	0.47
colon, fetal, donor1	10070-101I7	1391.09	8.03	32.75	3.71	0.62	0.62	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	1815.07	4.58	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	250.37	0.00	0.00	0.00	0.00	0.00	0.00	50.07
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3153.43	3.82	5.10	1.27	2.12	1.27	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2575.19	11.62	2.41	3.02	1.66	1.96	0.60	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	2731.67	3.10	1.55	4.51	2.40	3.10	0.71	0.99
corpus callosum, adult, pool1	10042-101F6	1279.10	2.65	0.00	1.33	0.44	0.88	0.77	0.11
cruciate ligament, donor2	10295-104G7	1257.04	2.43	34.85	4.05	0.81	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	1108.34	1.61	23.27	4.01	2.41	2.41	0.00	0.80
diencephalon, adult	10193-103E4	957.31	6.24	2.88	1.20	0.48	1.68	0.72	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	978.14	2.30	2.30	8.27	3.44	4.82	2.07	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	2911.36	3.33	2.56	1.03	0.26	2.05	0.51	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1251.03	3.13	1.44	1.93	0.72	1.69	0.96	0.72
ductus deferens, adult	10196-103E7	1055.48	5.48	6.48	5.48	1.50	1.50	1.50	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	1108.98	1.44	31.69	2.88	2.88	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	1151.29	5.89	8.09	9.56	3.68	7.36	6.62	0.74
dura mater, adult, donor1	10041-101F5	1113.61	4.05	0.00	1.32	0.33	0.99	0.25	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	1203.41	18.88	4.66	1.55	0.89	2.00	0.67	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	1637.84	11.61	0.29	1.29	1.15	2.29	0.00	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	2446.11	0.62	37.61	0.00	1.85	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	1205.09	3.03	8.17	3.33	1.51	1.51	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	2281.35	0.93	19.45	0.93	0.31	0.93	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	2766.16	1.31	28.90	0.00	0.00	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	1066.93	1.34	18.77	1.01	0.00	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1728.62	2.90	7.61	3.44	2.72	1.27	1.63	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	583.27	1.45	0.96	3.22	2.57	1.61	0.64	0.32
epidermoid carcinoma cell line:A431	10426-106D3	2079.22	6.45	12.56	0.56	0.22	1.45	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	1337.75	2.42	0.77	1.32	0.88	0.88	0.11	0.22
epididymis, adult	10197-103E8	1034.41	23.86	4.81	2.93	1.88	2.09	1.05	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	2165.65	2.66	2.84	3.73	2.66	1.95	0.35	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	889.51	2.75	1.57	1.97	0.39	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1360.82	3.28	0.39	6.95	3.80	3.15	1.57	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	1197.48	2.26	0.20	3.64	1.38	1.87	1.08	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1389.17	2.58	1.12	6.39	3.36	2.58	1.57	0.56
esophagus, adult, pool1	10015-101C6	1597.77	12.53	0.42	3.82	0.21	0.85	0.32	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3662.03	6.89	10.27	3.01	0.88	2.13	0.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	1219.36	0.00	28.97	0.00	0.00	7.24	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	1672.84	4.21	67.33	0.00	2.10	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1893.01	0.00	92.27	1.49	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	1451.46	1.15	66.50	1.15	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	963.34	0.00	0.00	1.46	0.00	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	1037.53	3.81	1.27	3.56	2.03	1.78	1.78	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	859.23	1.54	2.05	1.80	1.15	0.77	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	2362.08	6.89	24.22	3.32	1.42	1.19	0.47	0.71
frontal lobe, adult, pool1	10040-101F4	1226.37	1.78	0.00	0.84	0.47	0.75	0.56	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	3284.43	4.80	11.11	3.90	1.20	5.40	1.20	2.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1219.58	2.01	1.37	0.55	0.18	0.55	0.37	0.00
gall bladder, adult	10198-103E9	809.28	11.35	0.97	2.90	0.97	1.21	0.72	0.72
gamma delta positive T cells, donor1	11937-126A2	1098.40	4.29	1.07	2.15	3.22	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	931.11	1.49	0.00	1.12	1.49	0.00	1.12	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	1149.86	5.91	1.06	9.29	5.70	4.65	3.17	1.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	572.12	0.58	6.77	1.16	0.77	0.39	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	1399.85	1.80	2.62	0.49	0.66	0.82	0.33	0.16
gastric cancer cell line:GSS	10560-108A2	1151.35	3.66	5.49	1.83	1.83	2.75	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	703.65	2.97	5.25	3.88	1.83	0.91	0.46	0.46
giant cell carcinoma cell line:LU65	10487-107B1	660.68	1.49	0.57	1.49	0.92	0.80	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	1329.75	3.78	3.36	1.96	0.28	0.56	0.42	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	1760.89	3.99	30.43	2.49	1.75	2.24	1.25	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	1575.47	1.90	2.96	0.74	0.53	1.16	0.42	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	2176.94	1.26	8.57	0.70	0.56	0.98	0.70	0.70
glioblastoma cell line:T98G	10485-107A8	1351.85	1.77	0.88	1.77	1.66	1.32	0.22	0.88
glioma cell line:GI-1	10413-106B8	820.64	10.54	0.00	0.59	0.29	0.00	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	1454.18	2.19	3.64	0.00	0.73	2.19	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	1339.35	6.10	9.52	4.88	2.93	4.39	1.71	0.73
globus pallidus, adult, donor10258	10367-105F7	805.09	0.00	12.32	1.37	4.11	6.85	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	1135.11	9.06	0.53	2.66	1.60	0.53	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	2084.96	0.00	2.45	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	469.92	0.00	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	277.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	1715.81	1.92	4.80	3.20	1.28	0.96	0.96	0.64
hIPS +CCl2, biol_rep1	14383-156B9	1935.17	0.92	1.38	4.13	0.46	1.38	1.38	0.46
hIPS +CCl2, biol_rep2	14384-156C1	1657.12	0.91	1.37	3.66	0.91	4.12	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	2070.11	0.64	0.64	2.58	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	2610.11	0.00	0.00	1.44	0.00	0.00	1.44	1.44
hIPS, biol_rep2	14381-156B7	1656.37	0.69	0.69	2.06	0.69	2.74	0.00	1.37
hIPS, biol_rep3	14382-156B8	1497.41	0.00	3.31	4.41	1.10	1.10	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	1105.12	2.59	3.74	3.16	1.72	1.44	1.15	0.86
heart - mitral valve, adult	10205-103F7	1132.49	3.89	1.49	3.59	2.09	3.89	2.09	1.49
heart - pulmonic valve, adult	10206-103F8	1199.91	9.15	20.40	2.61	1.31	1.57	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	1338.06	3.33	40.80	0.83	1.67	2.50	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	1027.22	2.65	1.84	4.08	1.43	1.63	1.02	1.22
heart, adult, diseased, donor1	10051-101G6	1503.19	5.11	0.43	5.54	2.55	2.55	0.43	0.00
heart, adult, pool1	10016-101C7	2704.99	10.81	0.00	3.45	0.92	0.46	0.00	0.00
heart, fetal, pool1	10046-101G1	2008.52	2.36	0.82	2.36	0.62	0.92	0.62	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	1953.88	2.16	12.65	2.16	1.54	0.93	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	3656.72	0.00	35.68	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1626.61	3.09	2.54	5.52	2.43	2.32	0.99	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1554.68	3.88	2.43	6.55	2.43	3.03	1.34	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	1692.44	3.44	2.53	4.75	2.63	2.93	0.81	0.61
hepatoma cell line:Li-7	10484-107A7	1673.57	5.34	0.44	2.89	2.11	1.67	0.56	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1088.92	1.01	1.41	2.11	1.11	0.80	0.70	0.70
hippocampus - adult, donor10196	10169-103B7	1774.36	0.95	5.68	1.89	0.00	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	1223.17	5.71	2.04	4.69	3.06	1.63	0.61	0.82
hippocampus, adult, donor10258	10374-105G5	1260.81	0.00	1.49	1.49	0.50	0.50	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	1302.05	4.58	0.70	1.41	1.06	0.70	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2183.20	12.21	1.22	15.26	7.32	5.49	3.66	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1442.62	11.78	3.93	5.30	4.32	1.57	1.77	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1468.02	9.90	2.54	5.33	4.32	3.81	1.02	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1795.91	34.96	5.07	5.64	2.82	1.69	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1615.63	41.57	6.46	18.85	15.49	6.97	10.59	8.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1236.77	38.34	2.66	5.31	3.04	1.90	2.28	3.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1552.61	26.57	1.17	4.38	2.04	2.04	0.58	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1361.51	33.82	5.82	6.68	1.94	2.59	0.43	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1738.36	20.44	1.25	3.34	1.25	0.83	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1676.49	24.39	0.47	6.16	1.89	1.66	0.71	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1726.10	29.41	4.02	9.32	4.02	3.38	2.41	4.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	1857.64	23.57	0.67	2.69	1.35	3.37	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1201.17	12.68	3.44	5.79	3.13	2.50	1.72	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1345.16	13.76	3.93	17.20	7.86	4.42	7.86	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1915.69	16.58	1.75	9.60	6.98	4.36	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	2224.49	41.81	8.97	7.06	2.67	4.01	1.72	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	2378.34	28.34	6.98	3.92	2.18	0.87	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	2706.21	50.48	0.50	10.49	4.00	2.50	3.00	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	948.93	19.59	12.25	6.59	3.39	2.64	0.94	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1271.84	17.28	12.28	3.64	2.73	1.82	0.00	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1382.94	19.73	4.70	3.13	1.25	0.94	0.00	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	1677.93	25.80	8.82	9.96	4.57	4.74	1.47	2.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	1570.28	24.68	6.68	8.13	3.19	4.64	1.16	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	1896.37	27.80	3.59	5.38	3.29	1.79	0.90	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1453.94	16.63	4.99	6.84	4.99	2.77	2.03	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1676.90	8.56	5.99	6.85	1.71	2.28	0.57	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1902.73	23.27	1.22	7.76	3.67	2.45	1.63	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1664.64	28.87	4.22	13.03	7.04	3.52	3.17	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1670.81	21.86	7.92	7.29	0.32	2.85	0.63	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1496.76	29.96	3.33	5.45	1.82	2.72	2.72	3.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	1274.19	14.48	5.69	3.62	1.55	2.07	2.07	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	1650.45	11.95	8.63	3.98	0.00	1.99	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	837.07	18.21	1.03	4.36	2.57	2.31	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	1362.35	22.24	2.81	10.74	5.37	4.86	3.58	3.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	2068.73	22.72	4.54	9.09	2.27	4.54	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	1910.82	22.18	4.70	4.70	2.35	2.02	0.00	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1569.07	15.46	2.17	3.62	3.38	2.42	1.93	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1530.39	17.83	2.67	6.68	3.12	1.78	2.23	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1685.87	12.20	5.37	7.32	4.88	1.95	0.00	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1690.68	33.01	3.97	5.81	1.83	3.97	0.61	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4541.53	312.31	3.25	71.57	29.28	26.03	13.01	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2005.84	66.19	0.99	7.61	3.64	3.64	0.00	4.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1466.21	15.87	3.28	3.83	1.09	2.19	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1115.69	27.14	2.53	4.70	0.36	1.09	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1014.95	23.84	1.07	6.05	3.20	1.07	1.78	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1954.76	23.87	3.58	3.58	3.58	4.77	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	2307.24	40.63	1.49	4.60	0.68	2.57	0.41	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	1665.94	18.86	2.42	2.42	1.35	0.81	0.54	1.08
immature langerhans cells, donor1	11904-125F5	3834.14	2.66	3.39	5.09	2.42	2.66	0.73	1.21
immature langerhans cells, donor2	11905-125F6	1422.67	0.00	3.96	3.17	3.17	3.17	2.38	0.79
insula, adult, pool1	10039-101F3	1259.76	1.14	0.00	0.76	0.19	0.47	0.28	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	663.63	2.28	0.65	1.30	1.30	1.30	0.65	0.65
kidney, adult, pool1	10017-101C8	1740.51	6.91	1.90	1.90	1.20	1.30	0.80	0.40
kidney, fetal, pool1	10045-101F9	1092.16	1.84	0.14	0.42	0.57	0.57	0.28	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	3874.05	10.51	8.24	1.99	0.57	1.85	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	311.60	1.24	0.00	1.52	0.83	0.55	0.97	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	791.07	0.37	15.05	0.73	0.18	0.37	0.37	0.18
left atrium, adult, donor1	10079-102A7	1126.75	4.36	4.36	0.54	1.63	0.54	2.18	1.09
left ventricle, adult, donor1	10078-102A6	1480.56	4.55	5.56	2.02	2.02	2.53	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	5729.67	3.01	72.23	4.38	2.19	1.92	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	569.05	7.54	1.08	5.03	2.51	2.87	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	471.20	5.98	0.00	7.07	5.43	1.63	0.54	1.09
leiomyoma cell line:15425	10571-108B4	794.98	8.98	0.73	8.98	4.61	5.34	1.70	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	425.41	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	1024.64	4.18	8.36	3.14	0.00	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1241.97	1.53	4.25	1.65	1.06	0.71	0.71	0.12
liposarcoma cell line:KMLS-1	10782-110G8	719.66	1.25	2.50	0.78	0.47	0.78	0.78	0.62
liposarcoma cell line:SW 872	10726-110A6	1270.54	1.46	6.46	1.22	0.49	1.10	0.37	0.49
liver, adult, pool1	10018-101C9	1230.05	37.27	0.65	2.59	0.16	0.65	0.16	1.46
liver, fetal, pool1	10086-102B5	672.61	0.00	0.94	2.82	0.94	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	1622.74	1.31	7.87	1.75	0.29	0.73	0.58	0.44
locus coeruleus, adult, donor10252	10165-103B3	1171.90	2.58	2.21	3.69	2.40	2.03	1.11	0.92
locus coeruleus, adult, donor10258	10375-105G6	943.75	2.54	2.26	5.36	2.26	1.69	0.28	1.13
locus coeruleus, newborn, donor10223	10362-105F2	1904.56	24.40	3.79	5.05	2.52	1.68	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	2007.69	1.52	3.32	0.55	0.42	0.42	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	1846.92	0.69	2.07	0.00	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	1202.30	2.11	1.05	1.58	1.05	1.05	0.53	0.13
lung, adult, pool1	10019-101D1	1292.31	10.87	1.77	1.30	1.06	1.30	0.24	0.47
lung, fetal, donor1	10068-101I5	2695.67	12.56	5.71	3.14	1.14	1.71	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	1341.66	14.66	27.49	4.12	1.37	0.92	1.37	1.37
lymph node, adult, donor1	10077-102A5	784.36	2.84	2.37	3.31	0.95	0.47	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	1056.44	1.32	3.07	1.32	0.66	0.88	0.22	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1153.38	0.91	1.21	2.72	1.06	1.51	0.60	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	4043.60	13.59	33.98	3.40	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	2524.08	2.66	0.00	0.44	0.44	0.89	0.44	0.00
mature adipocyte, donor2	12232-129F9	2545.54	11.21	0.00	0.62	0.00	1.25	0.00	0.21
mature adipocyte, donor3	12233-129G1	1859.76	8.30	0.00	1.42	0.24	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	2115.21	6.32	0.00	0.79	0.00	1.05	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	3511.46	6.91	18.35	0.24	0.00	0.95	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	1921.04	3.38	5.64	6.77	1.13	3.38	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	1144.26	4.97	2.02	1.66	1.29	1.29	0.55	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	1665.32	3.49	1.27	0.64	0.95	1.27	0.95	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	2702.23	8.96	0.00	10.24	2.56	3.41	1.28	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	1557.23	11.64	1.52	14.18	7.43	8.94	5.23	2.70
medial temporal gyrus, adult, donor10252	10156-103A3	1295.84	6.79	2.33	1.27	2.12	3.18	0.42	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3218.78	0.00	3.85	1.93	1.93	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1406.65	0.00	0.00	0.00	0.00	0.00	14.35	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	1975.92	2.51	0.36	2.87	0.72	1.44	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	2043.63	1.95	9.73	5.84	0.00	1.30	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	1348.81	6.19	1.55	2.94	1.24	2.01	0.93	0.77
medulla oblongata, adult, pool1	10038-101F2	1144.33	1.71	0.08	0.82	0.24	0.65	0.24	0.16
medulla oblongata, newborn, donor10223	10361-105F1	1292.55	5.21	2.43	2.43	0.69	1.04	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	1227.51	3.54	3.32	5.76	3.10	1.77	0.89	0.66
medulloblastoma cell line:ONS-76	10759-110E3	3049.60	1.59	21.76	1.83	0.73	1.83	0.98	0.86
melanoma cell line:COLO 679	10514-107E1	1478.00	12.22	1.44	1.29	0.72	0.72	0.57	1.01
melanoma cell line:G-361	10465-106H6	1406.72	21.17	2.71	2.99	1.90	1.09	0.81	1.63
meningioma cell line:HKBMM	10691-109F7	413.37	1.99	0.90	5.25	2.71	2.17	1.63	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	1940.31	5.29	25.55	13.22	6.17	4.41	2.64	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	1790.20	3.89	4.15	6.22	5.18	2.85	0.52	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	685.08	3.99	0.46	2.15	2.15	1.07	1.07	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	581.88	1.45	0.00	1.64	0.36	0.91	1.09	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	689.48	4.14	0.00	2.07	2.48	1.24	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	422.69	1.40	0.14	0.84	0.98	0.00	0.56	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	395.73	1.16	0.00	0.77	2.50	0.77	0.19	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	692.00	2.78	1.39	3.47	0.69	2.08	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	349.28	2.40	0.00	1.37	1.37	0.00	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	436.37	4.14	0.12	0.81	2.19	1.15	0.81	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	585.86	2.39	0.13	2.52	0.80	0.27	0.27	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	623.21	1.76	0.14	1.22	1.89	1.22	1.22	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	722.41	1.71	0.00	1.99	1.42	1.28	0.28	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	627.09	2.31	1.98	0.66	0.66	0.99	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	749.56	2.21	0.14	1.94	1.80	0.14	0.28	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	998.38	1.40	0.70	2.09	2.09	3.49	0.70	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	440.18	1.84	0.00	1.02	2.86	1.43	1.22	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	617.90	3.24	1.80	1.80	1.44	1.80	0.00	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	485.28	2.28	0.10	0.72	0.93	0.72	0.72	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	573.63	1.60	0.00	2.51	0.91	1.37	0.46	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1008.20	8.81	0.42	2.52	2.10	2.94	0.00	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	504.05	3.29	0.15	1.49	1.64	0.60	0.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	599.50	2.63	0.26	1.14	0.96	0.79	0.70	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	612.62	0.74	0.37	1.10	1.10	1.47	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	677.05	5.15	1.14	2.00	2.86	1.72	0.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	1291.67	3.79	0.84	11.37	8.42	5.89	3.37	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	723.37	0.91	0.00	1.83	2.28	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	843.83	5.37	0.26	2.05	1.79	2.05	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	848.35	5.76	0.00	2.36	1.31	0.52	1.31	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	815.81	3.39	0.31	4.01	2.46	3.08	1.54	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	812.21	4.71	0.24	2.82	3.29	1.65	2.59	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	830.91	3.72	0.00	3.05	1.69	0.34	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	836.64	3.54	0.39	1.18	1.18	2.75	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	751.61	3.24	0.00	2.78	2.78	2.32	0.93	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	1014.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	858.62	6.06	0.29	4.04	1.44	1.15	0.87	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	795.80	4.02	0.45	2.45	2.45	1.78	0.89	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	837.14	3.85	0.24	1.68	2.64	1.44	0.72	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	1509.92	5.87	0.00	2.93	2.20	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	717.97	4.03	0.34	3.36	3.69	1.34	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	754.08	6.55	0.41	2.05	1.23	2.46	1.64	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	839.79	1.72	0.43	3.87	2.58	1.29	1.29	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	883.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	723.10	0.00	0.00	0.00	0.00	10.33	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	996.44	2.92	0.00	3.57	3.90	4.22	1.62	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	884.63	1.45	0.00	2.91	1.45	5.82	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	1094.95	5.33	0.00	3.73	1.60	3.73	1.07	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	835.76	0.82	0.00	2.45	2.45	1.64	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	992.40	2.33	0.78	3.11	1.94	1.55	0.78	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	833.19	2.10	0.00	14.69	4.20	12.59	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	861.34	2.98	0.00	2.98	0.99	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	686.48	0.00	0.00	4.77	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	1092.83	1.78	0.00	4.15	1.78	3.56	0.59	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	815.15	9.75	0.00	1.22	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	1109.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	938.67	2.53	0.00	4.43	0.63	1.90	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	981.94	3.79	1.72	1.38	0.69	2.76	1.38	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	713.54	0.00	0.00	6.45	2.15	2.15	2.15	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	590.79	0.00	0.00	3.99	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	626.79	3.44	0.00	3.44	3.44	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	525.64	0.81	0.81	1.63	2.44	1.22	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	490.97	0.79	0.00	0.79	2.38	1.59	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	521.14	2.36	0.00	4.13	2.36	1.18	0.59	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	741.86	1.87	0.31	1.87	0.62	1.25	0.94	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	542.69	4.01	0.00	2.67	4.01	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	617.35	2.37	0.00	3.55	3.55	2.37	1.18	4.73
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	703.63	0.00	0.00	12.84	7.70	7.70	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	539.01	2.07	0.00	5.51	4.82	0.00	3.44	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	504.70	1.98	0.00	2.97	2.97	0.99	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	437.39	1.12	0.00	2.24	4.49	2.24	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	553.38	3.18	1.91	7.00	1.91	1.27	1.27	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	558.13	1.61	0.00	1.21	0.81	0.40	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	523.34	2.18	0.00	4.36	0.00	2.18	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	401.66	1.27	0.00	1.27	3.80	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	484.90	2.43	0.00	1.82	0.61	0.61	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	546.80	4.52	0.00	4.52	4.52	9.04	4.52	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	420.08	0.00	0.00	4.12	4.12	0.82	4.12	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	848.47	2.58	0.20	0.79	0.60	1.79	0.99	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	554.24	0.32	0.97	1.95	1.30	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	452.27	6.11	0.00	4.07	6.11	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	3237.99	1.55	0.77	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	2423.60	3.07	17.72	1.42	0.71	0.94	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	2783.56	1.62	11.58	1.62	0.70	0.70	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	1183.79	12.82	0.00	4.27	8.55	0.00	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1613.49	2.47	0.00	6.27	6.88	2.67	1.23	1.64
mesothelioma cell line:Mero-25	10850-111F4	127.77	0.00	0.23	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	1697.88	3.42	0.98	5.62	4.16	5.13	2.44	1.47
mesothelioma cell line:Mero-48a	10852-111F6	1106.05	2.66	0.89	2.88	1.77	1.55	0.44	0.89
mesothelioma cell line:Mero-82	10853-111F7	979.74	2.10	1.84	4.20	2.63	4.99	2.89	0.53
mesothelioma cell line:Mero-83	10854-111F8	999.19	4.43	1.70	1.19	1.53	2.55	0.51	0.85
mesothelioma cell line:Mero-84	10855-111F9	598.57	0.51	0.51	1.26	1.52	2.02	0.25	1.01
mesothelioma cell line:Mero-95	10856-111G1	1149.09	3.93	0.83	2.48	2.48	0.62	0.83	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	1301.49	5.30	1.16	5.14	1.33	3.31	1.66	2.15
mesothelioma cell line:NCI-H226	10846-111E9	960.89	1.45	0.54	2.53	2.17	1.63	0.90	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	891.18	3.25	0.17	3.59	2.22	1.37	0.68	0.68
mesothelioma cell line:NCI-H28	10845-111E8	695.20	2.29	2.04	2.54	0.25	1.27	1.02	0.25
mesothelioma cell line:No36	10857-111G2	850.74	2.94	0.33	2.28	1.30	2.61	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	965.40	1.90	0.54	2.98	2.44	2.44	0.54	0.54
migratory langerhans cells, donor1	11901-125F2	1905.41	3.26	0.38	2.11	0.77	2.69	0.77	1.15
migratory langerhans cells, donor2	11902-125F3	2027.73	4.15	0.37	3.42	1.10	1.47	0.49	0.37
migratory langerhans cells, donor3	11903-125F4	1402.82	3.59	0.54	1.97	0.90	1.62	0.54	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	740.13	3.26	7.84	11.10	9.14	3.59	3.92	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	728.00	2.76	1.06	4.66	2.33	1.91	1.27	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	3493.37	0.46	22.34	1.84	0.46	1.15	0.46	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1378.67	5.71	3.04	2.47	1.14	1.33	0.57	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1648.16	0.37	2.22	2.40	1.66	2.03	0.92	0.92
myeloma cell line:PCM6	10474-106I6	1500.29	4.55	1.78	1.58	2.77	1.58	0.79	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	2728.71	2.54	7.61	0.51	0.00	0.51	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	827.51	2.55	0.78	0.98	1.18	0.98	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	565.03	1.11	0.00	0.45	0.33	0.56	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	683.56	1.69	0.00	0.88	0.59	0.51	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	1475.47	6.07	0.00	3.86	1.10	2.21	1.10	1.10
neuroblastoma cell line:CHP-134	10508-107D4	2697.46	3.45	17.25	0.92	0.69	0.46	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	1408.94	1.31	1.68	1.50	0.56	0.56	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	890.37	1.48	3.16	3.37	1.69	0.21	0.84	0.21
neuroblastoma cell line:NH-12	10555-107I6	1103.38	2.61	7.08	1.68	1.49	2.05	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	1201.79	2.14	27.99	3.56	2.61	1.19	0.47	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1059.09	4.12	6.81	5.38	3.01	1.11	0.63	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	829.59	0.60	2.62	0.81	1.21	1.21	0.40	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	3977.99	0.00	36.87	1.27	0.64	0.64	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	1830.16	2.40	15.97	1.60	1.60	1.06	0.27	0.00
neutrophil PMN, donor1	12133-128D9	1963.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	411.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	558.77	0.00	0.00	9.47	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1598.70	4.57	4.40	2.71	1.01	2.71	1.01	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1265.60	2.40	0.80	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	1116.03	4.49	1.28	7.37	2.89	0.64	1.60	2.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	970.39	4.47	0.79	4.99	9.20	4.20	2.89	1.58
nucleus accumbens, adult, pool1	10037-101F1	1100.68	2.34	0.09	1.31	0.66	0.28	0.28	0.19
occipital cortex - adult, donor10196	10172-103C1	1879.07	2.06	6.18	2.06	2.06	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	1351.21	5.10	3.22	3.22	1.61	3.22	1.34	0.54
occipital cortex, newborn, donor10223	10355-105E4	1756.03	5.10	0.36	2.91	1.46	1.82	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	615.59	19.68	6.30	3.15	2.89	2.89	0.52	1.05
occipital lobe, fetal, donor1	10073-102A1	4081.60	7.29	19.74	10.73	6.01	4.72	4.29	3.86
occipital pole, adult, pool1	10036-101E9	985.36	1.34	0.00	0.71	0.39	0.39	0.39	0.00
olfactory region, adult	10195-103E6	965.00	4.39	1.53	1.53	0.38	1.72	0.57	0.19
optic nerve, donor1	10277-104E7	1870.98	12.01	10.01	0.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	977.79	8.20	0.11	1.48	0.46	0.68	0.68	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1198.28	2.20	1.10	1.24	0.82	0.55	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	1660.56	6.43	10.33	7.45	5.42	5.59	2.37	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	774.14	1.85	0.46	2.19	1.04	1.27	0.46	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	1157.94	4.41	4.12	2.65	1.76	2.35	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	6159.14	1.87	12.15	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	1198.98	4.45	1.48	1.06	0.21	0.64	0.21	0.21
ovary, adult, pool1	10020-101D2	1054.07	16.86	0.26	1.48	0.26	1.14	0.09	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	1848.05	2.57	18.52	3.30	1.83	1.28	0.37	0.92
pancreas, adult, donor1	10049-101G4	977.32	3.76	0.94	6.58	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	2029.99	12.02	17.89	2.24	1.12	2.80	0.28	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	1020.42	3.07	2.38	7.50	6.64	3.58	2.21	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	1904.86	3.31	1.16	0.33	0.66	0.50	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	1090.58	2.01	0.09	1.46	0.27	0.82	0.27	0.46
parietal cortex, adult, donor10258	10373-105G4	1476.82	0.73	1.47	2.94	1.47	2.20	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	1556.50	2.82	0.00	4.70	0.00	0.00	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	1185.47	5.99	2.85	2.85	2.28	2.00	0.86	1.14
parietal lobe, adult, pool1	10034-101E7	1145.47	1.85	0.09	0.53	0.53	0.44	0.35	0.09
parietal lobe, fetal, donor1	10072-101I9	5349.61	10.67	29.10	12.61	2.91	4.85	0.97	3.88
parietal lobe, newborn, donor10223	10356-105E5	1866.31	4.86	2.62	4.11	0.00	1.87	0.37	0.00
parotid gland, adult	10199-103F1	856.55	7.40	0.00	1.23	2.47	0.62	0.62	0.00
penis, adult	10200-103F2	757.33	8.59	8.59	3.22	6.98	6.45	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	519.51	1.49	3.90	2.05	1.49	0.93	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	1428.68	2.33	5.25	3.64	2.91	1.89	0.44	0.73
pineal gland - adult, donor10196	10179-103C8	1669.98	0.65	5.16	0.65	0.00	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	2654.89	3.55	4.74	5.33	1.18	0.59	1.78	0.00
pineal gland, adult, donor10258	10377-105G8	1069.16	7.52	0.63	1.25	0.00	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	2171.32	16.19	0.00	6.07	1.01	1.01	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	3349.10	31.27	1.56	3.65	0.00	2.61	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	1308.36	23.83	2.55	4.26	0.85	0.85	2.55	0.00
placenta, adult, pool1	10021-101D3	2429.46	9.35	0.22	2.04	1.51	0.43	0.54	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	703.05	1.59	2.12	3.58	1.59	2.12	1.19	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	1271.26	2.65	2.65	1.09	0.47	0.31	0.62	0.16
pons, adult, pool1	10033-101E6	1136.52	3.79	0.09	0.95	0.60	0.17	0.34	0.34
postcentral gyrus, adult, pool1	10032-101E5	1021.26	1.48	0.00	1.05	0.44	0.52	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	1848.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	313.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	164.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	1350.43	2.18	0.58	3.79	1.60	1.89	1.02	0.87
prostate cancer cell line:PC-3	10439-106E7	4094.68	2.72	10.53	4.72	1.27	2.72	0.54	0.36
prostate, adult, pool1	10022-101D4	1309.32	8.98	0.73	1.00	0.54	0.45	0.27	0.63
putamen, adult, donor10196	10176-103C5	973.76	1.89	3.07	1.42	0.71	2.12	0.94	0.47
putamen, adult, donor10252	10152-102I8	1035.26	1.96	0.00	5.88	3.92	3.92	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	2125.51	1.09	2.19	3.28	0.00	3.28	1.09	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	750.21	1.69	2.42	1.69	0.24	1.93	0.48	0.72
putamen, newborn, donor10223	10365-105F5	2476.13	11.99	2.25	1.50	0.75	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	1750.85	1.45	38.69	0.58	0.00	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	1454.98	0.00	80.68	0.00	0.00	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	779.94	1.27	0.42	1.27	0.42	1.48	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	453.56	0.41	1.66	0.83	1.24	2.49	1.24	1.66
retina, adult, pool1	10030-101E3	1254.02	4.37	0.10	1.09	0.80	0.99	0.70	0.20
retinoblastoma cell line:Y79	10475-106I7	1403.97	2.08	7.79	2.60	2.60	1.82	1.82	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	1258.38	0.86	8.73	1.84	1.11	1.72	0.25	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	3681.47	3.09	64.68	0.28	0.00	0.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	2810.88	1.52	12.13	2.27	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	807.34	5.66	7.28	1.62	1.46	1.29	0.81	0.81
salivary acinar cells, donor2	11772-123I8	783.17	10.19	5.37	3.99	2.62	2.34	0.96	0.69
salivary acinar cells, donor3	11773-123I9	2444.96	1.32	45.02	1.99	0.66	2.65	0.00	0.00
salivary gland, adult, pool1	10093-102C3	1310.34	4.58	0.00	0.57	1.72	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	1506.14	8.68	0.42	2.87	1.60	1.18	0.51	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1936.20	6.23	0.94	2.23	0.59	0.82	0.47	0.35
seminal vesicle, adult	10201-103F3	1396.22	39.15	45.50	9.52	5.29	10.05	0.53	4.76
serous adenocarcinoma cell line:JHOS-2	10639-108I9	1118.18	2.92	4.37	5.59	2.92	1.46	1.21	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	734.51	2.26	0.75	2.01	2.26	2.01	0.75	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	1431.04	0.00	1.00	5.02	2.01	1.00	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	576.64	0.67	1.88	1.34	1.34	1.07	0.81	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	887.65	2.76	0.55	0.55	0.22	0.55	0.22	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	1637.59	3.35	1.42	1.68	1.68	0.90	0.65	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	2227.31	4.26	51.78	0.71	1.42	1.42	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	1835.64	31.54	1.44	1.44	0.60	0.96	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	1172.85	4.02	8.04	1.01	1.01	4.02	0.00	3.02
skin, adult, donor1	10074-102A2	1017.78	0.00	13.57	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	727.81	1.26	12.62	4.42	1.26	3.79	0.63	5.68
small cell cervical cancer cell line:HCSC-1	10800-110I8	1735.32	1.67	3.00	4.00	2.33	3.67	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1715.98	8.51	9.77	8.51	7.56	5.67	1.26	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	593.28	1.73	0.77	1.54	1.93	0.96	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	2536.69	4.29	7.75	1.32	0.66	1.65	0.33	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	440.08	1.29	4.66	1.77	0.97	1.45	0.48	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	1690.17	5.88	1.96	1.96	1.09	1.53	0.44	0.44
small intestine, adult, pool1	10024-101D6	1785.67	17.08	2.39	2.87	0.84	0.84	0.36	0.84
small intestine, fetal, donor1	10064-101I1	1234.62	1.97	3.69	3.69	1.47	1.23	1.23	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	517.00	2.56	5.64	5.13	6.15	2.56	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	954.22	3.62	1.81	4.65	0.78	1.03	1.03	0.00
somatostatinoma cell line:QGP-1	10781-110G7	2454.54	0.80	23.85	1.88	0.80	1.07	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	2088.28	5.51	9.41	5.05	2.06	2.06	2.06	0.92
spinal cord, adult, donor10252	10159-103A6	2073.47	2.37	2.37	3.15	0.39	1.58	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	1968.85	0.00	2.77	2.08	0.69	2.08	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	1089.17	5.49	20.12	6.10	1.83	1.22	3.05	1.83
spinal cord, newborn, donor10223	10359-105E8	1969.56	4.13	0.00	8.73	2.30	2.76	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	2098.13	1.64	5.38	2.09	2.24	1.94	0.45	0.15
spleen, adult, pool1	10025-101D7	1615.12	11.67	0.99	1.32	0.77	0.66	0.44	0.22
spleen, fetal, pool1	10044-101F8	1105.62	2.86	0.48	1.43	0.56	0.40	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	812.05	1.35	0.72	1.04	0.41	1.45	0.41	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1731.10	1.52	5.70	1.14	0.76	0.38	0.57	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	1146.20	3.49	1.75	7.34	6.29	3.84	2.45	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	1873.73	2.74	18.76	3.91	2.35	1.95	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1261.56	2.03	1.46	1.35	1.80	0.68	0.23	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	717.58	1.69	0.42	1.69	0.85	2.12	0.00	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	3754.33	6.35	8.46	4.23	2.12	3.38	0.42	1.27
stomach, fetal, donor1	10062-101H8	2884.60	0.00	189.03	3.20	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	972.44	17.66	5.70	9.11	6.84	2.85	0.57	2.85
substantia nigra - adult, donor10196	10178-103C7	2496.61	0.00	54.27	0.00	0.00	108.55	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	1149.65	6.65	3.74	3.12	1.25	2.08	0.21	0.83
substantia nigra, adult, donor10258	10371-105G2	1513.47	0.52	1.55	2.59	0.00	1.03	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	2172.72	5.65	2.83	2.12	0.00	2.12	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1804.78	2.06	3.67	2.06	2.75	1.83	0.69	1.15
temporal lobe, adult, pool1	10031-101E4	946.80	2.54	0.17	1.19	0.25	0.34	0.25	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	3734.42	5.70	16.38	12.11	2.85	9.26	2.14	8.55
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	2335.71	6.59	3.08	14.50	5.27	9.23	2.20	4.40
tenocyte, donor1	11763-123H8	910.80	3.14	0.35	6.28	9.43	5.24	2.44	2.79
tenocyte, donor2	11765-123I1	720.28	1.53	0.38	3.43	2.29	0.38	1.14	1.53
tenocyte, donor3	11768-123I4	714.27	1.85	1.11	5.56	2.97	0.37	2.22	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	2157.48	4.08	6.12	5.27	0.68	2.21	1.53	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	937.53	3.55	1.08	2.31	0.77	2.00	0.62	0.46
teratocarcinoma cell line:PA-1	10807-111A6	674.93	1.86	2.32	1.55	1.24	0.31	0.31	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	2001.33	12.82	11.68	2.29	1.14	0.51	1.02	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	2185.08	9.83	4.92	3.40	1.51	1.13	1.13	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	1090.95	7.42	3.60	0.87	2.07	1.31	0.33	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1740.23	10.10	9.45	9.77	6.84	3.26	1.95	0.65
testis, adult, pool1	10026-101D8	1358.05	41.88	0.75	2.68	1.93	1.29	0.32	0.86
testis, adult, pool2	10096-102C6	1347.39	5.41	0.90	5.86	2.26	5.41	1.35	0.90
thalamus - adult, donor10196	10168-103B6	2051.21	0.00	12.14	2.21	0.00	1.10	3.31	2.21
thalamus, adult, donor10252	10154-103A1	1229.79	5.31	1.25	3.44	1.09	2.50	0.63	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	3487.23	6.16	1.54	1.54	1.54	4.62	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	899.21	1.81	3.95	1.65	0.99	0.49	1.48	0.49
thalamus, newborn, donor10223	10366-105F6	2767.86	5.18	1.15	4.03	1.15	2.88	0.58	0.58
throat, adult	10209-103G2	746.26	17.98	2.00	3.25	4.24	5.49	1.25	1.75
throat, fetal, donor1	10061-101H7	1631.39	1.52	6.40	3.66	1.22	1.22	1.52	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	1146.28	0.79	5.96	2.78	0.20	2.58	0.60	0.20
thymus, adult, pool1	10027-101D9	1655.86	19.19	0.70	3.28	1.19	1.29	0.70	0.80
thymus, fetal, pool1	10043-101F7	1530.51	7.07	0.62	1.77	0.83	0.52	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	1565.35	3.06	2.53	2.13	1.20	2.79	0.53	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	1176.19	1.26	4.75	1.54	0.70	1.82	0.98	0.00
thyroid, adult, pool1	10028-101E1	1749.52	12.41	0.75	1.96	1.03	0.75	0.28	0.37
thyroid, fetal, donor1	10060-101H6	1790.53	3.16	13.97	5.54	2.11	2.64	2.37	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	1509.01	6.16	70.83	6.16	0.00	3.08	3.08	0.00
tongue, adult	10203-103F5	997.06	15.12	3.02	4.19	4.19	3.26	3.49	0.70
tongue, fetal, donor1	10059-101H5	1979.92	3.55	10.25	5.52	1.18	3.94	0.00	1.18
tonsil, adult, pool1	10047-101G2	1408.77	2.10	0.20	1.80	0.30	1.00	0.10	0.20
trachea, adult, pool1	10029-101E2	1422.48	8.92	0.41	1.31	0.33	1.15	0.33	0.49
trachea, fetal, donor1	10058-101H4	1477.61	3.85	7.31	5.77	1.92	1.92	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	1527.28	2.83	6.02	3.90	1.42	1.42	0.00	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	2817.00	6.69	1.22	1.52	1.32	1.11	0.30	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	1269.79	10.03	1.41	2.04	0.47	0.78	1.10	0.31
tridermal teratoma cell line:HGRT	10694-109G1	5869.30	1.90	3.81	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	793.26	1.69	2.71	0.68	0.34	0.76	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	1003.61	2.09	14.61	0.00	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	1810.37	5.12	0.51	1.02	0.68	1.19	0.34	0.34
uterus, fetal, donor1	10055-101H1	1708.82	2.56	11.26	7.68	0.00	2.56	1.02	2.05
vagina, adult	10204-103F6	1218.73	9.05	0.65	0.65	1.29	0.65	0.00	0.00
vein, adult	10191-103E2	982.23	16.22	1.97	2.85	2.41	1.10	0.66	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	462.24	0.80	1.34	1.07	0.27	0.27	0.53	0.27